CA2504965C - Vacuum device and method for treating tissue adjacent a body cavity - Google Patents
Vacuum device and method for treating tissue adjacent a body cavity Download PDFInfo
- Publication number
- CA2504965C CA2504965C CA2504965A CA2504965A CA2504965C CA 2504965 C CA2504965 C CA 2504965C CA 2504965 A CA2504965 A CA 2504965A CA 2504965 A CA2504965 A CA 2504965A CA 2504965 C CA2504965 C CA 2504965C
- Authority
- CA
- Canada
- Prior art keywords
- body cavity
- vacuum
- sheath
- wall
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1014—Intracavitary radiation therapy
- A61N5/1015—Treatment of resected cavities created by surgery, e.g. lumpectomy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
- A61B2017/22047—Means for immobilising the guide wire in the patient
- A61B2017/22048—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
Abstract
Devices and methods are provided for applying vacuum near to devices for delivering treatments to tissue adjacent a body cavity, effective to draw adjacent tissue near to such devices and to enhance treatment of the tissue. Body cavities include natural body cavities and cavities remaining after removal of tissue such as cancerous tissue. A device may include an inner balloon assembly with an inflation conduit. A sheath assembly having a fluid-permeable sheath wall may enclose the inner balloon assembly. Vacuum applied to the space between the sheath and the inner balloon is useful to draw tissue into contact with the device, improving treatment effectiveness. Methods for treating tissue with such devices and systems are also provided. Treatment may include providing radioactive material for radiation treatment, providing chemotherapeutic material for chemotherapy, providing thermal treatment, and combinations thereof. Systems may include devices of the invention and a vacuum source.
Description
VACUUM DEVICE AND METHOD FOR TREATING TISSUE ADJACENT A BODY
CAVITY
FIELD OF THE INVENTION
[0001] This invention relates generally to the fields of medical treatment devices and methods. In particular, the invention relates to devices and methods for treating tissue surrounding a body cavity, such as a site from which cancerous, pre-cancerous, or other tissue has been removed.
BACKGROUND OF THE INVENTION
CAVITY
FIELD OF THE INVENTION
[0001] This invention relates generally to the fields of medical treatment devices and methods. In particular, the invention relates to devices and methods for treating tissue surrounding a body cavity, such as a site from which cancerous, pre-cancerous, or other tissue has been removed.
BACKGROUND OF THE INVENTION
[0002] In diagnosing and treating certain medical conditions, it is often desirable to perform a biopsy, in which a specimen or sample of tissue is removed for pathological examination, tests and analysis. A biopsy typically results in a biopsy cavity occupying the space formerly occupied by the tissue that was removed. As is known, obtaining a tissue sample by biopsy and the subsequent examination are typically employed in the diagnosis of cancers and other malignant tumors, or to confirm that a suspected lesion or tumor is not malignant.
Treatment of cancers identified by biopsy may include subsequent removal of tissue surrounding the biopsy site, leaving an enlarged cavity in the patient's body. Cancerous tissue is often treated by application of radiation, by chemotherapy, or by thermal treatment (e.g., local heating, cryogenic therapy, and other treatments to heat, cool, or freeze tissue).
Treatment of cancers identified by biopsy may include subsequent removal of tissue surrounding the biopsy site, leaving an enlarged cavity in the patient's body. Cancerous tissue is often treated by application of radiation, by chemotherapy, or by thermal treatment (e.g., local heating, cryogenic therapy, and other treatments to heat, cool, or freeze tissue).
[0003] Cancer treatment may be directed to a natural cavity, or to a cavity in a patient's body from which tissue has been removed, typically following removal of cancerous tissue during a biopsy or surgical procedure. For example, U.S.
Patent 5,429,582 to Williams, U.S. Patent 5,913,813 to Williams et al., U.S. Patent 5,931,774 to Williams et al., U.S. Patent 6,022,308 to Williams, U.S. Patent 6,083,148 to Williams, and U.S. Patent 6,413, 204 to Winkler et al., describe devices for implantation into a cavity resulting from the removal of cancerous tissue which can be used to deliver cancer treatments to surrounding tissue.
One form of radiation treatment used to treat cancer near a body cavity remaining following removal of tissue is "brachytherapy" in which a source of radiation is placed near to the site to be treated.
Patent 5,429,582 to Williams, U.S. Patent 5,913,813 to Williams et al., U.S. Patent 5,931,774 to Williams et al., U.S. Patent 6,022,308 to Williams, U.S. Patent 6,083,148 to Williams, and U.S. Patent 6,413, 204 to Winkler et al., describe devices for implantation into a cavity resulting from the removal of cancerous tissue which can be used to deliver cancer treatments to surrounding tissue.
One form of radiation treatment used to treat cancer near a body cavity remaining following removal of tissue is "brachytherapy" in which a source of radiation is placed near to the site to be treated.
[0004] Williams and coworkers describe implantable devices for treating tissue 1o surrounding a cavity left by surgical removal of cancerous or other tissue that includes an inflatable balloon constructed for placement in the cavity. Such devices may be used to apply one or more of radiation therapy, chemotherapy, and thermal therapy to the tissue surrounding the cavity from which the tissue was removed. The balloon may be filled with a treatment fluid delivered via a conduit from a receptacle, syringe, or other means, or may receive a solid radiation source placed within the balloon. Thus, radiation treatment may be applied to tissue adjacent the balloon by placing radioactive material such as radioactive "seeds" within the balloon, or by filling the balloon with a liquid or slurry containing radioactive material. Multiple treatments may be applied simultaneously. For example, radioactive seeds may be placed within the balloon effective to irradiate tissue surrounding the balloon, and the balloon filled with a hot fluid at the same time to provide thermal treatment. After a suitable time, the hot fluid and/or the radioactive seeds may be removed. Such treatments, combined or otherwise, may be repeated if desired.
[0005] For example, a "MammoSite Radiation Therapy System"
(MammoSite RTS, Proxima Therapeutics, Inc., Alpharetta, GA 30005 USA) includes a balloon catheter with a radiation source that can be placed within a tumor resection cavity in a breast after a lumpectomy. It can deliver a prescribed dose of radiation from inside the tumor resection cavity to the tissue surrounding the original tumor. The radiation source is typically a solid radiation source; however, a liquid radiation source may also be used with a balloon catheter placed within a body cavity (e.g., lotrex , Proxima Therapeutics, Inc.). The radiation source may be removed following each treatment session, or may remain in place as long as the balloon remains within the body cavity. Inflatable treatment delivery devices and systems, such as the MammoSite RTS and similar devices and systems (e.g., GliaSite RTS (Proxima Therapeutics, Inc.)), are useful to treat cancer in tissue adjacent a body cavity.
(MammoSite RTS, Proxima Therapeutics, Inc., Alpharetta, GA 30005 USA) includes a balloon catheter with a radiation source that can be placed within a tumor resection cavity in a breast after a lumpectomy. It can deliver a prescribed dose of radiation from inside the tumor resection cavity to the tissue surrounding the original tumor. The radiation source is typically a solid radiation source; however, a liquid radiation source may also be used with a balloon catheter placed within a body cavity (e.g., lotrex , Proxima Therapeutics, Inc.). The radiation source may be removed following each treatment session, or may remain in place as long as the balloon remains within the body cavity. Inflatable treatment delivery devices and systems, such as the MammoSite RTS and similar devices and systems (e.g., GliaSite RTS (Proxima Therapeutics, Inc.)), are useful to treat cancer in tissue adjacent a body cavity.
[0006] However, radiation, chemotherapy, thermal treatment, and other cancer treatments often have deleterious effects on healthy tissue in addition to the desired effects on cancerous tissue. In such treatments, care must be taken to direct the maximum treatment effects to diseased tissue while minimizing its delivery or effects on healthy tissue. For example, radiation treatment may be most effective when all surrounding tissue regions receive the same dose of radiation, and where the radiation dosage received by more distant tissue is as small and as uniform as possible. However, tissue cavities typically are not uniform or regular in their sizes and shapes, so that differences in dosages applied to different regions of surrounding tissue, including "hot spots" and regions of relatively low dosage, often result from radiation treatment.
[0007] Thus, there is need in the art for improved devices and methods for delivering cancer treatment to a cavity site within a patient's body.
SUMMARY OF THE INVENTION
SUMMARY OF THE INVENTION
[0008] The invention provides assemblies, devices, systems, and methods for treating tissue adjacent a body cavity, such as a cavity formed by the removal of tissue from a patient. In methods and devices having features of the invention, vacuum is applied effective to draw tissue towards a treatment assembly placed within the body cavity. Assemblies and devices embodying features of the invention include a vacuum delivery element configured to apply a vacuum. A vacuum delivery element may include a vacuum conduit, and may further include a vacuum port. A vacuum delivery element may be configured to at least partially surround or enclose a treatment assembly. A treatment assembly may be configured to deliver a treatment, such as radiation therapy, chemotherapy, thermal therapy, or other treatment, to tissue adjacent a body cavity. A treatment assembly may include a treatment delivery element configured to contain a treatment material, such as a radioactive source. A treatment assembly may include an inflatable balloon, which may be disposed at least in part around a treatment delivery element.
[0009] Assemblies and devices embodying features of the invention may include a vacuum delivery element such as a sheath or a balloon configured to provide vacuum effective to apply suction to tissue adjacent the assemblies and devices. Vacuum delivery elements are preferably configured to apply suction to tissue adjacent a treatment delivery assemblies, such as an inflatable treatment delivery device. Suction is effective to draw surrounding tissue close to the surface of a treatment assembly, or to a vacuum delivery element (such as a sheath or balloon) at least partially surrounding or enclosing a treatment assembly, so as to shape the tissue lining the body cavity for optimal treatment. Treatment may be by, e.g., radiation therapy, chemotherapy, thermal therapy, or other treatment modality supplied by the device. A treatment assembly may include an inflatable treatment assembly such as an inner balloon assembly configured to be at least partly enclosed by a vacuum delivery element such as a sheath or balloon. A sheath may be configured to at least partly enclose a balloon temporarily, following placement over or around an inner balloon. A balloon may be configured to at least partly enclose a balloon permanently following placement over or around an inner balloon.
[0010] Devices may further include an enclosure assembly (which may comprise a sheath assembly or a balloon assembly) comprising a vacuum conduit and a fluid-permeable enclosure wall (e.g., a sheath wall or a balloon wall) configured to partly or completely enclose an inner balloon assembly. Such an enclosure assembly may be effective to provide vacuum and a vacuum path to an intermediate space outside the inner balloon assembly. An intermediate space may include a space disposed between the inner balloon assembly and a sheath assembly or an outer balloon assembly. The enclosure assembly is preferably operatively connected to a vacuum conduit effective to provide vacuum to the intermediate space. Systems having features of the invention include such devices and further include a vacuum source configured to operatively connect with the vacuum conduit. In embodiments of devices having features of the invention, a fluid-permeable enclosure wall may have a hole or multiple holes configured to allow passage of fluid, may be made with a fluid-permeable material, such as a fluid-permeable woven material, or may be otherwise fluid-permeable. The space between the inner balloon and the enclosure may be prevented from collapse, even in the presence of suction from a vacuum delivered via the vacuum conduit, by separation elements disposed on the inner balloon wall, or on the enclosure wall, or both. In alternative embodiments, separation elements disposed within an intermediate space may be independent of both the inner balloon wall and the enclosure wall.
[0011] An embodiment of a device for treating tissue adjacent a body cavity having features of the invention further comprises an inner balloon assembly, which may include or be operatively connected with an inflation conduit configured to allow passage of a fluid. Devices may also have an inner balloon comprising a distensible inner balloon wall defining an internal lumen. Such an inner balloon may be operatively connected to an inflation conduit so as to allow for passage of fluid through an inflation conduit and into the internal lumen so as to inflate the inner balloon with the fluid.
[0012] An enclosure wall preferably comprises a flexible material, more preferably an elastic flexible material, although in embodiments of the invention, an eneclosure wall may comprise an inelastic flexible material. In embodiments of devices and systems having features of the invention, an enclsoure wall comprises a polymer, such, as biocompatible polymer, preferably a radiation-resistant polymer.
Suitable polymers include polyolefins such as polyethylene and polypropylene, polyurethanes, polyester, polyvinyichloride, polystyrene, thermoplastic polymers such as C-Flex (Consolidated Polymer Technologies, Inc., Clearwater FL
33762), block polymers such as KratonTM (Kraton Polymers, Houston TX 77208), an ionomer such as Surlyn (Dupont, Wilmington DE 19880), nylon, latex rubber, and silicon rubber (e.g., SILASTICTM, Dow Corning, Midland, MI).
Suitable polymers include polyolefins such as polyethylene and polypropylene, polyurethanes, polyester, polyvinyichloride, polystyrene, thermoplastic polymers such as C-Flex (Consolidated Polymer Technologies, Inc., Clearwater FL
33762), block polymers such as KratonTM (Kraton Polymers, Houston TX 77208), an ionomer such as Surlyn (Dupont, Wilmington DE 19880), nylon, latex rubber, and silicon rubber (e.g., SILASTICTM, Dow Corning, Midland, MI).
[0013] Devices and systems having features of the invention include inner balloon assemblies configured to enclose a treatment material, such as radioactive material, chemotherapeutic agents, and thermal treatment materials (e.g., materials having a temperature greater than about 37 C).
[0014] The invention further provides methods for treating tissue adjacent a body cavity, comprising contacting tissue adjacent a body cavity with a sheath or an outer balloon having a fluid-permeable wall of a device having features of the invention; and applying a vacuum effective to enhance the contact between the fluid- permeable wall and the tissue. Further methods may include delivering inflation fluid to an inner balloon lumen via an inflation conduit to inflate a distensible balloon. In embodiments of the methods of the invention, the inner balloon assembly comprises a treatment assembly such as a Mammosite RTS or similar inflatable treatment delivery device. Methods may io include placing a treatment material within the device, and may further include replacing the treatment material.
[0015] Body cavities are typically not uniform in size or regular in shape.
Devices, systems and methods having features of the invention utilize suction to draw tissue against the device surface within a body cavity, insuring good contact between the device and body tissue and providing control over the spacing between tissue and the device, including control over the distance from the treatment material contained within the devices. Tissue lining a body cavity that is held close to, or in contact with, devices having features of the invention forms a uniform and controlled surface, unlike tissue lining a body cavity in which a prior art treatment device has been merely inserted, but which does not urge tissue into a desired orientation and position. The control over the distance, spacing, and amount of tissue contact provided by devices, systems and methods of the present invention offer the advantages of improved treatment tissue adjacent a body cavity. Such improvements may include more uniform dosing, reduction of "hot spots," shorter treatments due greater correlation between desired and actual dosages, and reduction in the number of locations receiving inadequate dosages.
[0015A] In accordance with a broad aspect, the invention provides a device for irradiating tissue forming at least in part a body cavity. The device comprises an elongated shaft having a proximal shaft section, a distal shaft section and an irradiation location in the distal shaft section. The device also comprises a treatment member, which surrounds the irradiation location on the distal shaft section and which is configured for deployment within the body cavity. The device further comprises at least one vacuum port in a distal portion of the device configured to be in fluid communication with the body cavity when the treatment member is disposed therein and a vacuum lumen leading to the vacuum port to develop a vacuum within the body cavity to conform the tissue forming the body cavity to the treatment member in order to deliver an effective dose of therapeutic irradiation from a radiation source at the irradiation location io to tissue forming the body cavity.
[0015B] In accordance with another broad aspect, the invention also provides a device for treating tissue adjacent a body cavity. The device comprises an elongated shaft having proximal and distal portions and having an inflation lumen, a vacuum lumen and a therapeutic agent delivery lumen in at least a distal portion of the shaft. The device also comprises an inner balloon assembly having a distensible inner balloon wall defining an interior chamber in fluid communication with the inflation lumen so as to allow for passage of inflation fluid through the inflation lumen into the interior chamber. The device further comprises a receptacle within the interior chamber of the inner balloon wall in fluid communication with the therapeutic agent delivery lumen and configured to receive a therapeutic agent therefrom. The device further comprises an outer sheath assembly having a fluid-permeable sheath wall enclosing at least in part the inner balloon wall and defining an intermediate space between the inner balloon wall and the sheath wall and configured to be in fluid communication with the vacuum lumen and provide vacuum to the intermediate space.
[0015C] In accordance with yet another broad aspect, the invention further provides a system for treating tissue adjacent a body cavity. The system comprises an elongated shaft having proximal and distal portions and having an inflation lumen, a vacuum lumen and a therapeutic agent delivery lumen in at least a distal portion of the shaft. The system also comprises an inner balloon assembly having a distensible inner balloon wall defining an interior chamber in fluid communication with the inflation lumen so as to allow for passage of inflation fluid through the inflation lumen into the interior chamber. The system further comprises an outer sheath assembly having a fluid-permeable sheath wall enclosing at least in part the inner balloon wall defining an intermediate space between the inner balloon wall and the sheath wall and configured to be in fluid communication with the vacuum lumen and provide vacuum to the intermediate space. The system yet further comprises a vacuum source operatively configured to be in fluid communication with the vacuum lumen.
[0015D] In accordance with another broad aspect, the invention further provides a device for treating tissue adjacent a body cavity. The device comprises an inner balloon assembly including an inflation conduit configured to allow passage of a fluid and an inner balloon comprising a distensible inner balloon wall defining an internal lumen. The inner balloon is operatively connected to the inflation conduit so as to allow for passage of the fluid through the inflation conduit and into the internal lumen effective to inflate the inner balloon with the fluid. The device also comprises a sheath assembly comprising a vacuum conduit and a fluid-permeable sheath wall configured to enclose the inner balloon assembly, effective to define an intermediate space between the inner balloon assembly and the sheath assembly. The sheath assembly is operatively connected to the vacuum conduit effective to provide vacuum to the intermediate space.
[0015E] In accordance with yet another broad aspect, the invention further provides a device for treating tissue adjacent a body cavity. The device comprises an elongated shaft having proximal and distal portions and having an inflation lumen and a therapeutic agent delivery lumen in at least a distal portion of the shaft. The device also comprises a balloon assembly having a 3o distensible balloon wall defining an interior chamber in fluid communication with the inflation lumen so as to allow for passage of inflation fluid through the inflation lumen into the interior chamber. The device further comprises a receptacle within the interior chamber of the balloon wall in fluid communication with the therapeutic agent delivery lumen and configured to receive a therapeutic agent therefrom.
BRIEF DESCRIPTION OF THE DRAWINGS
Devices, systems and methods having features of the invention utilize suction to draw tissue against the device surface within a body cavity, insuring good contact between the device and body tissue and providing control over the spacing between tissue and the device, including control over the distance from the treatment material contained within the devices. Tissue lining a body cavity that is held close to, or in contact with, devices having features of the invention forms a uniform and controlled surface, unlike tissue lining a body cavity in which a prior art treatment device has been merely inserted, but which does not urge tissue into a desired orientation and position. The control over the distance, spacing, and amount of tissue contact provided by devices, systems and methods of the present invention offer the advantages of improved treatment tissue adjacent a body cavity. Such improvements may include more uniform dosing, reduction of "hot spots," shorter treatments due greater correlation between desired and actual dosages, and reduction in the number of locations receiving inadequate dosages.
[0015A] In accordance with a broad aspect, the invention provides a device for irradiating tissue forming at least in part a body cavity. The device comprises an elongated shaft having a proximal shaft section, a distal shaft section and an irradiation location in the distal shaft section. The device also comprises a treatment member, which surrounds the irradiation location on the distal shaft section and which is configured for deployment within the body cavity. The device further comprises at least one vacuum port in a distal portion of the device configured to be in fluid communication with the body cavity when the treatment member is disposed therein and a vacuum lumen leading to the vacuum port to develop a vacuum within the body cavity to conform the tissue forming the body cavity to the treatment member in order to deliver an effective dose of therapeutic irradiation from a radiation source at the irradiation location io to tissue forming the body cavity.
[0015B] In accordance with another broad aspect, the invention also provides a device for treating tissue adjacent a body cavity. The device comprises an elongated shaft having proximal and distal portions and having an inflation lumen, a vacuum lumen and a therapeutic agent delivery lumen in at least a distal portion of the shaft. The device also comprises an inner balloon assembly having a distensible inner balloon wall defining an interior chamber in fluid communication with the inflation lumen so as to allow for passage of inflation fluid through the inflation lumen into the interior chamber. The device further comprises a receptacle within the interior chamber of the inner balloon wall in fluid communication with the therapeutic agent delivery lumen and configured to receive a therapeutic agent therefrom. The device further comprises an outer sheath assembly having a fluid-permeable sheath wall enclosing at least in part the inner balloon wall and defining an intermediate space between the inner balloon wall and the sheath wall and configured to be in fluid communication with the vacuum lumen and provide vacuum to the intermediate space.
[0015C] In accordance with yet another broad aspect, the invention further provides a system for treating tissue adjacent a body cavity. The system comprises an elongated shaft having proximal and distal portions and having an inflation lumen, a vacuum lumen and a therapeutic agent delivery lumen in at least a distal portion of the shaft. The system also comprises an inner balloon assembly having a distensible inner balloon wall defining an interior chamber in fluid communication with the inflation lumen so as to allow for passage of inflation fluid through the inflation lumen into the interior chamber. The system further comprises an outer sheath assembly having a fluid-permeable sheath wall enclosing at least in part the inner balloon wall defining an intermediate space between the inner balloon wall and the sheath wall and configured to be in fluid communication with the vacuum lumen and provide vacuum to the intermediate space. The system yet further comprises a vacuum source operatively configured to be in fluid communication with the vacuum lumen.
[0015D] In accordance with another broad aspect, the invention further provides a device for treating tissue adjacent a body cavity. The device comprises an inner balloon assembly including an inflation conduit configured to allow passage of a fluid and an inner balloon comprising a distensible inner balloon wall defining an internal lumen. The inner balloon is operatively connected to the inflation conduit so as to allow for passage of the fluid through the inflation conduit and into the internal lumen effective to inflate the inner balloon with the fluid. The device also comprises a sheath assembly comprising a vacuum conduit and a fluid-permeable sheath wall configured to enclose the inner balloon assembly, effective to define an intermediate space between the inner balloon assembly and the sheath assembly. The sheath assembly is operatively connected to the vacuum conduit effective to provide vacuum to the intermediate space.
[0015E] In accordance with yet another broad aspect, the invention further provides a device for treating tissue adjacent a body cavity. The device comprises an elongated shaft having proximal and distal portions and having an inflation lumen and a therapeutic agent delivery lumen in at least a distal portion of the shaft. The device also comprises a balloon assembly having a 3o distensible balloon wall defining an interior chamber in fluid communication with the inflation lumen so as to allow for passage of inflation fluid through the inflation lumen into the interior chamber. The device further comprises a receptacle within the interior chamber of the balloon wall in fluid communication with the therapeutic agent delivery lumen and configured to receive a therapeutic agent therefrom.
BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 is partially cut-away perspective view of a system embodying features of the invention shown configured to deliver a treatment within a cavity in a patient's body tissue while providing vacuum effective to urge tissue into contact with an outer balloon surface.
[0017] Figure 2 is a longitudinal cross-sectional view of the system of Fig. 1 taken along line 2-2.
[0018] Figure 3 is a transverse cross-sectional view of the system of Fig. I
taken along line 3-3.
taken along line 3-3.
[0019] Figure 4A is a cross-sectional view of a system of Fig. 1 showing a pie-shaped section of balloon walls between lines 4-4 for an embodiment in which an outer wall has stand-offs.
[0020] Figure 4B is a cross-sectional view of the system of Fig. 1 showing a pie-shaped section of balloon walls between lines 4-4 for an embodiment in which an inner wall has stand-offs.
[0021] Figure 5A shows a perspective view of a system embodying features of the invention in which an outer balloon assembly, in the form of a sheath, is being fitted over an inner balloon assembly.
[0022] Figure 5B shows a cross-sectional view of the assembled outer and inner balloon assemblies of Figure 5A following placement into a cavity within a breast of a patient and before inflation of the inner balloon assembly.
[0023] Figure 5C shows a cross-sectional view of the assembled outer and inner balloon assemblies of Figure 5A following inflation of the inner balloon assembly.
[0024] Figure 5D shows a cross-sectional view of the assembled outer and inner balloon assemblies of Figure 5A following application of vacuum to the lumen separating the inner balloon assembly and the outer balloon assembly, and after placement of a radioactive assembly within the inner balloon assembly.
[0025] Figure 6A is perspective view of a system embodying features of the invention including a vacuum delivery element configured to partly enclose an inner balloon assembly.
[0026] Figure 6B is a cross-sectional view of the system of Figure 6A taken along line 6B-6B.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0027] The present invention provides devices and methods for delivering a treatment, such as a cancer treatment, into a cavity within the body of an animal.
For example, devices and methods having features of the invention may be used to deliver treatments into a biopsy site or into a cavity left after removal of cancerous tissue from within the body of a human patient. Vacuum is applied to tissue to enhance contact between a treatment delivery assembly within a body cavity and tissue surrounding the body cavity. A vacuum path around the treatment assembly is provided by devices, systems and methods embodying features of the invention.
Vacuum may be applied to tissue via one, two, or multiple vacuum ports. A
vacuum port may be a port in a vacuum delivery conduit, a hole in a sheath or balloon connected to a vacuum delivery conduit. A fluid permeable wall or portion of a fluid permeable wall may be effective to serve as a vacuum port.
For example, devices and methods having features of the invention may be used to deliver treatments into a biopsy site or into a cavity left after removal of cancerous tissue from within the body of a human patient. Vacuum is applied to tissue to enhance contact between a treatment delivery assembly within a body cavity and tissue surrounding the body cavity. A vacuum path around the treatment assembly is provided by devices, systems and methods embodying features of the invention.
Vacuum may be applied to tissue via one, two, or multiple vacuum ports. A
vacuum port may be a port in a vacuum delivery conduit, a hole in a sheath or balloon connected to a vacuum delivery conduit. A fluid permeable wall or portion of a fluid permeable wall may be effective to serve as a vacuum port.
[0028] Figure 1 is a perspective view of a system 10 embodying features of the invention illustrating a device 12 having an outer balloon 14 enclosing an inner balloon 16 (shown in the cut-away portion of the illustration), a shaft 18 and connector 20. Outer balloon 14 comprises a sheath assembly around inner balloon 16. Outer balloon 14 is thus an example of an enclosure assembly, and forms an enclosure wall around inner balloon 16. Outer balloon 14 comprises at least in part a fluid permeable wall; as illustrated in Figure 1, outer balloon 14 has holes 22 allowing fluid permeation into and out of balloon 14. In alternative embodiments, an outer balloon 14 may be made of woven or otherwise substantially continuous materials that are fluid permeable. In further embodiments, an enclosure wall or assembly such as an outer balloon may comprise a net, mesh, framework, or other discontinuous structure. Holes 22 (or fluid permeable material) allows fluids to pass through outer balloon 14 into intermediate space 24 disposed outside inner balloon 16. Intermediate space 24 provides a vacuum path adjacent inner balloon 16.
Where at least a portion of outer balloon 14 is disposed adjacent inner balloon 16, intermediate space 24 is disposed between outer balloon 14 and inner balloon 16.
Where at least a portion of outer balloon 14 is disposed adjacent inner balloon 16, intermediate space 24 is disposed between outer balloon 14 and inner balloon 16.
[0029] Inner balloon 16 defines an inner lumen 26, within which a delivery shaft 28 may be at least partially contained. As shown in Figure 2, a treatment material 30 may be permanently or transiently disposed within delivery shaft 28. A
probe 32 configured to move within delivery shaft 28 may be used to position treatment material 30, including to place treatment material 30 into and to retrieve placement material 30 from, within delivery shaft 28. A vacuum conduit 34 may be part of, or may be contained within, a shaft 18 and operatively connected to intermediate space 24. Shaft 18 may also include or contain an inflation conduit 36 configured to allow passage of inflation fluid into inner lumen 26. Passage of inflation fluid into inner lumen 26 is effective to inflate inner balloon 16.
Inflation fluid may be any suitable fluid, either a gas or a liquid, and is typically inert.
Inflation fluid, where a gas, may be, e.g., air, nitrogen, carbon dioxide or other gas.
Inflation fluid, where a liquid, may be water, saline, mineral oil, or other liquid. In some embodiment, an inflation fluid may be effective to absorb radiation to, for example, moderate or adjust a dosage of radiation delivered to a patient's tissue from radioactive treatment material 30 contained within a delivery shaft 28.
probe 32 configured to move within delivery shaft 28 may be used to position treatment material 30, including to place treatment material 30 into and to retrieve placement material 30 from, within delivery shaft 28. A vacuum conduit 34 may be part of, or may be contained within, a shaft 18 and operatively connected to intermediate space 24. Shaft 18 may also include or contain an inflation conduit 36 configured to allow passage of inflation fluid into inner lumen 26. Passage of inflation fluid into inner lumen 26 is effective to inflate inner balloon 16.
Inflation fluid may be any suitable fluid, either a gas or a liquid, and is typically inert.
Inflation fluid, where a gas, may be, e.g., air, nitrogen, carbon dioxide or other gas.
Inflation fluid, where a liquid, may be water, saline, mineral oil, or other liquid. In some embodiment, an inflation fluid may be effective to absorb radiation to, for example, moderate or adjust a dosage of radiation delivered to a patient's tissue from radioactive treatment material 30 contained within a delivery shaft 28.
[0030] Vacuum applied to intermediate space 24 is effective to deliver a treatment within a body cavity 38 within a patient's body effective to urge surrounding tissue into contact with at least a portion of the surface of the outer balloon 14.
[0031] The outer balloon 14 shown in Figs. 1-5 is illustrated as a balloon that is configured to permanently or semi-permanently enclose inner balloon 16 or inner balloon assembly. Such an enclosure may be partial or complete. It will be understood that the outer surface of a device and of a system embodying features of the invention may also be a sheath 50 configured for deployment over and around an inner balloon assembly 14. In further embodiments, an enclosure may be, e.g. a net, mesh, framework, or other discontinuous structure.
[0032] Figure 2 is a longitudinal cross-sectional view of the system of Fig. 1 taken along line 2-2 showing in cross section, for example, the relative positions of treatment material 30, an inner balloon 16, and an outer balloon 14 or sheath 50.
Figure 2 includes cross-sectional views of shaft 18 including views of delivery shaft 28, vacuum conduit 34 and inflation conduit 36. Figure 3 is a transverse cross-sectional view of the system of Fig. 1 taken along line 3-3 showing outer balloon 14 and holes 22 therethrough, inner balloon 16 disposed within outer balloon 14, delivery shaft 28 and probe 32.
Figure 2 includes cross-sectional views of shaft 18 including views of delivery shaft 28, vacuum conduit 34 and inflation conduit 36. Figure 3 is a transverse cross-sectional view of the system of Fig. 1 taken along line 3-3 showing outer balloon 14 and holes 22 therethrough, inner balloon 16 disposed within outer balloon 14, delivery shaft 28 and probe 32.
[0033] Figure 4A and 4B show portions of outer balloon 14 and inner balloon 16 as indicated in Figure 1, including intermediate space 24 and spacers 40 which serve as separation elements effective to maintain patency of intermediate space 24 even under the influence of vacuum supplied via vacuum conduit 34. Spacers 40 may be part of outer balloon 14, or of inner balloon 16, or both. A spacer 40 may be a bump, knob, ridge, or other feature extending inwardly from an inner surface 42 of outer balloon 14, or extending outwardly from an outer surface 44 of outer balloon 14. In addition, or alternatively, a spacer 40 may be an object that is placed within intermediate space 24 and is separate from outer balloon 14 and inner balloon 16.
For example, as shown in Figures 4A and 4B, spacers 40 may be stand-offs extending from an inner surface 42 of outer balloon 14 and from an outer surface 44 of outer balloon 14.
For example, as shown in Figures 4A and 4B, spacers 40 may be stand-offs extending from an inner surface 42 of outer balloon 14 and from an outer surface 44 of outer balloon 14.
[0034] Figures 5A-5D illustrate the fitting of an outer balloon assembly 46 (including an outer balloon in the form of a sheath 50), over an inner balloon assembly 48 including an inner balloon 16. Figure 5B shows the assembled outer 46 and inner 48 balloon assemblies of Figure 6A following placement into a cavity 38 within a breast 52 of a patient and before inflation of the inner balloon assembly 48.
In Figure 5C, the inner balloon assembly 48 has been inflated by passage of inflation fluid through inflation conduit 36, pressing some parts of the outer surface 54 outer balloon assembly 46 into contact with portions of the inner surface 56 of body cavity 38. Note, however, that since most cavities 38 have irregular inner surfaces 56, there will typically be poor and intermittent contact between outer surface 54 of sheath 50 (or outer balloon 14 in alternative embodiments) and inner surface 56 of cavity 38, as shown in Figure 5C.
In Figure 5C, the inner balloon assembly 48 has been inflated by passage of inflation fluid through inflation conduit 36, pressing some parts of the outer surface 54 outer balloon assembly 46 into contact with portions of the inner surface 56 of body cavity 38. Note, however, that since most cavities 38 have irregular inner surfaces 56, there will typically be poor and intermittent contact between outer surface 54 of sheath 50 (or outer balloon 14 in alternative embodiments) and inner surface 56 of cavity 38, as shown in Figure 5C.
[0035] Figure 5D shows the assembled outer 46 and inner 48 balloon assemblies of Figure 5A following application of vacuum via vacuum conduit 34 to the intermediate space 24 separating the inner balloon 16 and the sheath 50 (outer balloon 14). Treatment material 30 is in place within delivery shaft 28. Note that inner surface 56 of cavity 38 has been pulled into intimate contact with outer surface 54 of sheath 50. Such intimate contact configures inner surface 56 into an optimal configuration for the application of treatment by a treatment material 30. For example, radiation treatment by a radiation treatment material 30 is enhanced by proper positioning of adjacent tissue to provide proper irradiation.
Irradiation levels may vary widely where the adjacent tissue of tissue cavity 38 is at different, irregular, or improper distances from a radiation source. Application of vacuum effective to draw tissue into better contact with device 12, e.g., into better contact with outer surface 54 of sheath 50, is effective to improve the delivery of radiation treatment from a radioactive treatment material 30.
Irradiation levels may vary widely where the adjacent tissue of tissue cavity 38 is at different, irregular, or improper distances from a radiation source. Application of vacuum effective to draw tissue into better contact with device 12, e.g., into better contact with outer surface 54 of sheath 50, is effective to improve the delivery of radiation treatment from a radioactive treatment material 30.
[0036] Figure 6A illustrates a system embodying features of the invention including a vacuum delivery element comprising an enclosure 60 having ribs 62 configured to partly enclose an inner balloon assembly 48. Vacuum is delivered to intermediate space 24 via vacuum ports 64 operatively connected to vacuum conduit 34. As shown in cross-section in Figure 6B, ribs 62 serve as separation elements effective to provide vacuum paths in the intermediate space 24 between tissue surface 56 and outer surface 44 of inner balloon assembly 48.
[0037] Methods for treating tissue adjacent a body cavity 38 include methods for delivering a treatment to tissue adjacent a device 12 embodying features of the invention. For example, a method of treating tissue adjacent a body cavity 38 includes contacting tissue adjacent the body cavity 38 with a sheath 50 or an outer balloon 14, and applying a vacuum via vacuum conduit 34. The vacuum may be effective to draw adjacent tissue towards and into contact with a sheath 50 or an outer balloon 14, and so enhance the contact between the outer wall 54 and the tissue. Delivery of inflation fluid to an inner balloon 16 via an inflation conduit 36 to inflate inner balloon 16 is effective to enhance contact with adjacent tissue as well, serving to bring outer balloon 14 or sheath 50 closer to tissue than it would be in the absence of inflation of inner balloon 16. In preferred embodiments, the inner balloon assembly 48 comprises an inflatable treatment delivery device such as a Mammosite RTS (Proxima Therapeutics, Inc., Alpharetta, GA 30005) or similar device.
[0038] Methods further include placing a treatment material 30, such as a radiation source, within the device (e.g., by placement within a delivery shaft 28). A
radiation source, such as a solid radiation source (e.g., a brachytherapy seeds) may be advanced into a delivery shaft 28 with a probe 32 or by other means. Other solid treatment materials 30 may similarly be advanced into a delivery shaft 28 with a probe 32 or by other means. A liquid radiation source (e.g., lotrex , Proxima Therapeutics, Inc., Alpharetta, GA) may be advanced into a delivery shaft 28 by fluid flow, under the influence of gravity, pressure applied by a syringe or other pressure source, or other means for delivering fluid into a space. Similarly, hot liquids and other liquid treatment materials 30 may be introduced into a delivery shaft 28 or an inner balloon 16 (via inflation conduit 36) under the influence of gravity, pressure applied by a syringe or other pressure source, or other means for delivering fluid into a space.
radiation source, such as a solid radiation source (e.g., a brachytherapy seeds) may be advanced into a delivery shaft 28 with a probe 32 or by other means. Other solid treatment materials 30 may similarly be advanced into a delivery shaft 28 with a probe 32 or by other means. A liquid radiation source (e.g., lotrex , Proxima Therapeutics, Inc., Alpharetta, GA) may be advanced into a delivery shaft 28 by fluid flow, under the influence of gravity, pressure applied by a syringe or other pressure source, or other means for delivering fluid into a space. Similarly, hot liquids and other liquid treatment materials 30 may be introduced into a delivery shaft 28 or an inner balloon 16 (via inflation conduit 36) under the influence of gravity, pressure applied by a syringe or other pressure source, or other means for delivering fluid into a space.
[0039] Some treatment regimens may include periodic or episodic treatment, in which radiation or other treatment is applied for a treatment period, and then the treatment is stopped for a recovery period. Such periodic or episodic treatments may be repeated, so that treatment is applied during a first treatment period, stopped during a first recovery period, and then treatment is re-applied for a second treatment period. Further treatment periods and recovery periods may also be used as necessary. Thus, methods may further include removal of a radiation source or other treatment material 30 from within a delivery shaft 28, and may further include replacing the treatment material 30.
[0040] Although a cavity 38 is typically an artificial cavity remaining after removal of tissue at biopsy, surgery, or other medical procedure, a body cavity may be a natural body cavity. For example, devices 12 may be inserted into a bladder for the treatment of bladder cancer. Application of suction is effective to enhance contact with a device 12 in such an example as well. Such enhanced contact may be effective to improve the delivery of radiation or other treatment, and may be effective to avoid "hot spots" (tissue regions receiving more radiation than is received by neighboring tissue regions) and is one of the important advantages provided by the present invention.
[0041] Treatment material 30 may include a chemotherapy agent effective to treat cancer or other disease condition of tissue surrounding a body cavity 38. In preferred embodiments, treatment material 30 includes a radiation source configured to delivery radiation to tissue adjacent a device 12.
[0042] Thus, treatment material 30 may include a radiation source which may be solid or liquid. A liquid radiation source may include, for example, a liquid containing a radioactive iodine isotope (e.g., 1251 or 1311), a slurry of a solid isotope, e.g. 198AU, 90Y, 169Yb, or a gel containing a radioactive isotope. Liquid radiation sources are commercially available (e.g., lotrex , Proxima Therapeutics, Inc., Alpharetta, GA).
[0043] A solid radiation source may include brachytherapy seeds or other solid radiation source used in radiation therapy, such as, for example, a radioactive microsphere available from the 3M company of St. Paul, MN. A solid radioactive source can either be preloaded into a device 12 at the time of manufacture or may be loaded into the device 12 after placement into body cavity 38 of a distal portion of the device 12. Such distal portion preferably includes the outer balloon 14, inner balloon 16, and at least a portion of delivery shaft 28. Such a solid radioactive core configuration offers the advantage in that it allows a wider range of radionuclides than if one is limited to liquids. Solid radionuclides suitable for use with a delivery device embodying features of the present invention are currently generally available as brachytherapy radiation sources (e.g., I-PlantTM, Med-Tec, Orange City IA).
[0044] In general, the amount of radiation desired by the physician is a certain minimum amount that is delivered to a site about 0-3 cm away from the wall of the body cavity 38 (e.g., from where a tumor has been excised). Vacuum applied to intermediate space 24 effects good contact between tissue surrounding body cavity 38 and the wall of the outer balloon 14 or sheath 50, promoting effective treatment delivery, such as delivery of radiation to surrounding tissue. It is desirable to keep the radiation in the region near the wall of the outer balloon 14 or sheath 50 as uniform as possible to prevent over-exposure to tissue at or near the reservoir wall.
It is well known that the absorbed dose rate at a point exterior to a radioactive source is inversely proportional to the square of the distance between the radiation source and the target point. Thus, it is possible that the radiation dosage delivered to adjacent tissue may differ from that delivered to tissue disposed at more distal locations. In some instances, penetration of radiation to locations far from a device 12 is not desired. For example, in treating cancers such as bladder cancer, where the neoplastic tissue is generally located on the bladder surface, deep penetration is unnecessary and to be avoided.
It is well known that the absorbed dose rate at a point exterior to a radioactive source is inversely proportional to the square of the distance between the radiation source and the target point. Thus, it is possible that the radiation dosage delivered to adjacent tissue may differ from that delivered to tissue disposed at more distal locations. In some instances, penetration of radiation to locations far from a device 12 is not desired. For example, in treating cancers such as bladder cancer, where the neoplastic tissue is generally located on the bladder surface, deep penetration is unnecessary and to be avoided.
[0045] An inflation fluid may also be a radiation absorbing fluid. For example, an inflation fluid may be an X-ray contrast agent as used in angiography, such as a Barium salt (e.g., barium sulfate), water, saline or other such fluid. A
radiation-absorbing inflation fluid, which will surround a radiation source placed within delivery shaft 28, serves to moderate and control the delivery of radiation from the radiation source to surrounding tissue. Such moderation and control that is obtained with a radiation-absorbing inflation fluid may aid in avoiding the delivery of an excessive amount of radiation to some portions of the surrounding tissue.
radiation-absorbing inflation fluid, which will surround a radiation source placed within delivery shaft 28, serves to moderate and control the delivery of radiation from the radiation source to surrounding tissue. Such moderation and control that is obtained with a radiation-absorbing inflation fluid may aid in avoiding the delivery of an excessive amount of radiation to some portions of the surrounding tissue.
[0046] Thus, in the absence of such a radiation-absorbing inflation fluid, it is possible in some instances that a radiation source sufficient to provide an effective dose at distances removed from a device 12, would expose tissue that is directly adjacent the wall of the outer balloon 14 or sheath 50 to an excessive radiation dose.
Such excessive exposure to such tissue near to the device 12 may result in necrosis of healthy tissue necrosis.
Such excessive exposure to such tissue near to the device 12 may result in necrosis of healthy tissue necrosis.
[0047] Alternatively, an inflation fluid may contain radioactive elements, either as a liquid or slurry, so that the inner balloon 16 is filled with a source of radiation, providing a fairly uniform source of radiation that is distributed over the volume of the inner balloon 16. In such embodiments, an inflation fluid thus itself serves as a radiation source, thereby providing well-controlled amounts of radiation to surrounding tissue while minimizing irregularities in the dosages delivered to particular locations.
[0048] In embodiments of the invention in which an inflation fluid includes a radiation source, a delivery shaft 28 may contain a radiation absorptive material, so that, for example, less volume of radioactive material is required than if the entire volume of a device 12 were filled with radioactive material. Such a configuration may be advantageous where a profile exhibiting higher intensity at a tissue surface with lesser penetration is desired. Moreover, the outer balloon 14 need not be spherical, yet a uniform profile of radiation delivery is obtainable.
Experiments reported in Williams U.S. Pat. No. 5,918,813 are described as showing that a steeper radial absorbed source gradient can be obtained using a radiation attenuation fluid in an inner chamber of a similar radiation deliver device than otherwise obtains with a device having only a single distensible chamber (as described in Williams U.S. Pat. No. 5,429,582).
Experiments reported in Williams U.S. Pat. No. 5,918,813 are described as showing that a steeper radial absorbed source gradient can be obtained using a radiation attenuation fluid in an inner chamber of a similar radiation deliver device than otherwise obtains with a device having only a single distensible chamber (as described in Williams U.S. Pat. No. 5,429,582).
Claims (67)
What is claimed is:
1. A device for irradiating tissue forming at least in part a body cavity, comprising:
a. an elongated shaft having a proximal shaft section, a distal shaft section and an irradiation location in the distal shaft section;
b. an treatment member which surrounds the irradiation location on the distal shaft section and which is configured for deployment within the body cavity; and c. at least one vacuum port in a distal portion of the device configured to be in fluid communication with the body cavity when the treatment member is disposed therein and a vacuum lumen leading to the vacuum port to develop a vacuum within the body cavity to conform the tissue forming the body cavity to the treatment member in order to deliver an effective dose of therapeutic irradiation from a radiation source at the irradiation location to tissue forming the body cavity.
a. an elongated shaft having a proximal shaft section, a distal shaft section and an irradiation location in the distal shaft section;
b. an treatment member which surrounds the irradiation location on the distal shaft section and which is configured for deployment within the body cavity; and c. at least one vacuum port in a distal portion of the device configured to be in fluid communication with the body cavity when the treatment member is disposed therein and a vacuum lumen leading to the vacuum port to develop a vacuum within the body cavity to conform the tissue forming the body cavity to the treatment member in order to deliver an effective dose of therapeutic irradiation from a radiation source at the irradiation location to tissue forming the body cavity.
2. The device of claim 1 wherein at least one vacuum port is proximal to the treatment member.
3. The device of claim 1 wherein at least one vacuum port is distal to the treatment member.
4. The device of claim 1 wherein at least one vacuum port is proximal to the treatment member and at least one vacuum port is distal to the treatment member.
5. The device of claim 1 wherein the treatment member has at least one vacuum port.
6. The device of claim 2 wherein at least one vacuum lumen is in fluid communication with the at least one vacuum port proximal to the treatment member.
7. The device of claim 3 wherein at least one vacuum lumen is in fluid communication with the at least one vacuum port distal to the treatment member.
8. The device of claim 5 wherein at least one vacuum lumen is in fluid communication with the at least one vacuum port of the treatment member.
9. The device of claim 1 wherein the treatment member is expandable.
10. The device of claim 9 wherein the expandable treatment member is an inflatable balloon with an interior configured to receive inflation fluid.
11. The device of claim 10 wherein the shaft has an inflation lumen which extends to the distal shaft section and which is in fluid communication with the interior of the balloon.
12. The device of claim 10 wherein the inflatable balloon has at least one rib on the exterior thereof.
13. The device of claim 12 wherein the at least one rib is configured to space at least part of the tissue adjacent the cavity away from an exterior surface of the balloon.
14. The device of claim 10, wherein the balloon is formed at least in part of a polymeric material.
15. The device of claim 14 wherein the polymeric material is flexible material.
16. The device of claim 14, wherein the polymeric material is elastic material.
17. The device of claim 14, wherein the polymeric material is inelastic material.
18. The device of claim 14, wherein the polymeric material is a biocompatible polymer.
19. The device of claim 14, wherein the polymeric material is at least in part radiation-resistant.
20. The device of claim 14, wherein the polymeric material is selected from the group consisting of a polyolefin, polyethylene, polypropylene, polyurethane, polyester, polyvinylchloride, polystyrene, nylon, latex rubber, silicon rubber and a thermoplastic polymer.
21. The device of claim 14, wherein the polymeric material is polyester.
22. The device of claim 14, wherein the polymeric material is nylon.
23. The device of claim 14 wherein the polymeric material is a thermoplastic polymer.
24. The device of claim 1 wherein the treatment member has a spherical shape.
25. The device of claim 14 wherein the balloon has a spherical shape in an inflated condition.
26. The device of claim 10 wherein a sheath assembly comprising a fluid-permeable sheath wall which is disposed about and encloses the treatment member, which is effective to define an intermediate space between the treatment member and the sheath and which is in fluid communication with the vacuum conduit to provide vacuum to the intermediate space.
27. The device of claim 26, wherein the fluid-permeable sheath wall has at least one hole therethrough.
28. The device of claim 26, wherein the fluid-permeable sheath wall is formed at least in part of a fluid-permeable material.
29. The device of claim 28, wherein the fluid-permeable material is a woven material.
30. The device of claim 26, wherein the sheath wall includes separation elements configured to maintain a separation between the sheath wall and the balloon.
31. The device of claim 26, wherein the balloon has separation elements configured to maintain a separation between the sheath wall and the balloon.
32. The device of claim 26, wherein the sheath wall is at least in part formed of a flexible material.
33. The device of claim 32, wherein the sheath wall is at least in part formed an elastic flexible material.
34. The device of claim 32, wherein the sheath wall is at least in part formed of an inelastic flexible material.
35. The device of claim 26, wherein the sheath wall is at least in part formed of a polymer.
36. The device of claim 35, wherein the sheath wall is at least in part formed of a biocompatible polymer.
37. The device of claim 35, wherein the sheath wall is at least in part formed of a radiation-resistant polymer.
38. The device of claim 35, wherein the polymer is selected from the group consisting of a polyolefin, a polyethylene, a polypropylene, a polyurethane, a polyester, a polyvinylchloride, a polystyrene, a nylon, a latex rubber, a silicon rubber, a thermoplastic polymer, C-Flex ®, a monomer, Surlyn®, Kraton .TM. and SILASTIC.TM..
39. The device of claim 1, where an internal lumen is configured to enclose a treatment material.
40. The device claim 39, wherein the treatment material is selected from the group consisting of radioactive material, chemotherapeutic agents, and materials having a temperature greater than about 37° C.
41. The device of claim 26, wherein the sheath is configured to enclose a treatment material.
42. The device of claim 41, wherein the treatment material is selected from the group consisting of radioactive material, chemotherapeutic agents, and materials having a temperature greater than about 37° C.
43. A device for treating tissue adjacent a body cavity, comprising:
a. an elongated shaft having proximal and distal portions and having an inflation lumen, a vacuum lumen and a therapeutic agent delivery lumen in at least a distal portion of the shaft;
b. an inner balloon assembly having a distensible inner balloon wall defining an interior chamber in fluid communication with the inflation lumen so as to allow for passage of inflation fluid through the inflation lumen into the interior chamber;
c. a receptacle within the interior chamber of the inner balloon wall in fluid communication with the therapeutic agent delivery lumen and configured to receive a therapeutic agent therefrom; and d. an outer sheath assembly having a fluid-permeable sheath wall enclosing at least in part the inner balloon wall and defining an intermediate space between the inner balloon wall and the sheath wall and configured to be in fluid communication with the vacuum lumen and provide vacuum to the intermediate space.
a. an elongated shaft having proximal and distal portions and having an inflation lumen, a vacuum lumen and a therapeutic agent delivery lumen in at least a distal portion of the shaft;
b. an inner balloon assembly having a distensible inner balloon wall defining an interior chamber in fluid communication with the inflation lumen so as to allow for passage of inflation fluid through the inflation lumen into the interior chamber;
c. a receptacle within the interior chamber of the inner balloon wall in fluid communication with the therapeutic agent delivery lumen and configured to receive a therapeutic agent therefrom; and d. an outer sheath assembly having a fluid-permeable sheath wall enclosing at least in part the inner balloon wall and defining an intermediate space between the inner balloon wall and the sheath wall and configured to be in fluid communication with the vacuum lumen and provide vacuum to the intermediate space.
44. The device for treating tissue adjacent a body cavity of claim 43, wherein said fluid-permeable sheath wall has at least one hole therethrough.
45. The device for treating tissue adjacent a body cavity of claim 43, wherein said fluid-permeable sheath wall is formed at least in part of a fluid-permeable material.
46. The device for treating tissue adjacent a body cavity of claim 45, wherein said fluid-permeable material is a woven material.
47. The device for treating tissue adjacent a body cavity of claim 43, wherein separation elements are disposed between the sheath wall and the inner balloon wall.
48. The device for treating tissue adjacent a body cavity of claim 43, wherein separation elements are on an outer surface of the inner balloon wall.
49. The device for treating tissue adjacent a body cavity of claim 43, wherein said sheath wall is formed at least in part of a flexible material.
50. The device for treating tissue adjacent a body cavity of claim 49, wherein said sheath wall is formed at least in part of an elastic flexible material.
51. The device for treating tissue adjacent a body cavity of claim 50, wherein said sheath wall is formed at least in part an inelastic flexible material.
52. The device for treating tissue adjacent a body cavity of claim 43, wherein said sheath wall is formed at least in part of a polymeric material.
53. The device for treating tissue adjacent a body cavity of claim 52, wherein the polymeric material is a biocompatible polymer.
54. The device for treating tissue adjacent a body cavity of claim 52, wherein the polymeric material is at least in part a radiation-resistant polymer.
55. The device for treating tissue adjacent a body cavity of claim 52, wherein the polymeric material is selected from the group of polymers consisting of a polyolefin, polyethylene, polypropylene, polyurethane, polyester, polyvinylchloride, polystyrene, nylon, latex rubber, silicon rubber, a thermoplastic polymer.
56. The device for treating tissue adjacent a body cavity of claim 43, wherein the treatment lumen is configured to deliver a treatment agent within the interior chamber defined by the inner balloon wall.
57. The device for treating tissue adjacent a body cavity of claim 56, wherein the treatment agent is selected from the group consisting of radioactive material, chemotherapeutic agents, and materials having a temperature greater than about 37° C.
58. The device for treating tissue adjacent a body cavity of claim 43, wherein the sheath wall forms an outer balloon wall disposed about the inner balloon wall.
59. The device for treating tissue adjacent a body cavity of claim 58, wherein the outer balloon wall is formed at least in part of a polymeric material.
60. The device for treating tissue adjacent a body cavity of claim 59, wherein the polymeric material is selected from the group of polymers consisting of a polyolefin, polyethylene, polypropylene, polyurethane, polyester, polyvinylchloride, polystyrene, nylon, latex rubber, silicon rubber, a thermoplastic polymer.
61. The device for treating tissue adjacent a body cavity of claim 58, wherein the outer balloon wall is configured to enclose a treatment agent.
62. The device for treating tissue adjacent a body cavity of claim 61, wherein the treatment agent is selected from the group consisting of radioactive material, chemotherapeutic agents, and materials having a temperature greater than about 37° C.
63. The device of claim 43, wherein outer sheath is at least in part fluid permeable.
64. The device of claim 43, wherein said treatment agent is a material selected from the group consisting of radioactive material, chemotherapeutic agents, and thermal treatment materials.
65. The device for treating tissue adjacent a body cavity of claim 43, wherein separation elements are on an inner surface of the sheath.
66.A system for treating tissue adjacent a body cavity, comprising:
a. an elongated shaft having proximal and distal portions and having an inflation lumen, a vacuum lumen and a therapeutic agent delivery lumen in at least a distal portion of the shaft;
b. an inner balloon assembly having a distensible inner balloon wall defining an interior chamber in fluid communication with the inflation lumen so as to allow for passage of inflation fluid through the inflation lumen into the interior chamber;
c. an outer sheath assembly having a fluid-permeable sheath wall enclosing at least in part the inner balloon wall defining an intermediate space between the inner balloon wall and the sheath wall and configured to be in fluid communication with the vacuum lumen and provide vacuum to the intermediate space; and d. a vacuum source operatively configured to be in fluid communication with the vacuum lumen.
a. an elongated shaft having proximal and distal portions and having an inflation lumen, a vacuum lumen and a therapeutic agent delivery lumen in at least a distal portion of the shaft;
b. an inner balloon assembly having a distensible inner balloon wall defining an interior chamber in fluid communication with the inflation lumen so as to allow for passage of inflation fluid through the inflation lumen into the interior chamber;
c. an outer sheath assembly having a fluid-permeable sheath wall enclosing at least in part the inner balloon wall defining an intermediate space between the inner balloon wall and the sheath wall and configured to be in fluid communication with the vacuum lumen and provide vacuum to the intermediate space; and d. a vacuum source operatively configured to be in fluid communication with the vacuum lumen.
67. A device for treating tissue adjacent a body cavity, comprising:
an inner balloon assembly including an inflation conduit configured to allow passage of a fluid and an inner balloon comprising a distensible inner balloon wall defining an internal lumen, said inner balloon being operatively connected to said inflation conduit so as to allow for passage of said fluid through said inflation conduit and into said internal lumen effective to inflate said inner balloon with said fluid;
and a sheath assembly comprising a vacuum conduit and a fluidpermeable sheath wall configured to enclose said inner balloon assembly, effective to define an intermediate space between said inner balloon assembly and said sheath assembly, said sheath assembly being operatively connected to said vacuum conduit effective to provide vacuum to said intermediate space.
an inner balloon assembly including an inflation conduit configured to allow passage of a fluid and an inner balloon comprising a distensible inner balloon wall defining an internal lumen, said inner balloon being operatively connected to said inflation conduit so as to allow for passage of said fluid through said inflation conduit and into said internal lumen effective to inflate said inner balloon with said fluid;
and a sheath assembly comprising a vacuum conduit and a fluidpermeable sheath wall configured to enclose said inner balloon assembly, effective to define an intermediate space between said inner balloon assembly and said sheath assembly, said sheath assembly being operatively connected to said vacuum conduit effective to provide vacuum to said intermediate space.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/290,002 US6923754B2 (en) | 2002-11-06 | 2002-11-06 | Vacuum device and method for treating tissue adjacent a body cavity |
US10/290,002 | 2002-11-06 | ||
PCT/US2003/033775 WO2004043531A2 (en) | 2002-11-06 | 2003-10-28 | Vaccum device for treating tissus adjacent a body cavity |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2504965A1 CA2504965A1 (en) | 2004-05-27 |
CA2504965C true CA2504965C (en) | 2012-07-03 |
Family
ID=32176127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2504965A Expired - Fee Related CA2504965C (en) | 2002-11-06 | 2003-10-28 | Vacuum device and method for treating tissue adjacent a body cavity |
Country Status (10)
Country | Link |
---|---|
US (7) | US6923754B2 (en) |
EP (2) | EP2305340B1 (en) |
JP (1) | JP4563180B2 (en) |
AT (1) | ATE511874T1 (en) |
AU (1) | AU2003283014A1 (en) |
CA (1) | CA2504965C (en) |
DK (1) | DK1558324T3 (en) |
ES (1) | ES2365331T3 (en) |
PT (1) | PT1558324E (en) |
WO (1) | WO2004043531A2 (en) |
Families Citing this family (157)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1272113B1 (en) * | 2000-04-07 | 2012-03-21 | Kyphon SÀRL | Insertion devices |
US7815649B2 (en) * | 2000-04-07 | 2010-10-19 | Kyphon SÀRL | Insertion devices and method of use |
US8845672B2 (en) * | 2002-05-09 | 2014-09-30 | Reshape Medical, Inc. | Balloon system and methods for treating obesity |
DE60324448D1 (en) | 2002-09-10 | 2008-12-11 | Cianna Medical Inc | brachytherapy |
US8123698B2 (en) * | 2002-10-07 | 2012-02-28 | Suros Surgical Systems, Inc. | System and method for minimally invasive disease therapy |
US6923754B2 (en) * | 2002-11-06 | 2005-08-02 | Senorx, Inc. | Vacuum device and method for treating tissue adjacent a body cavity |
US8328710B2 (en) * | 2002-11-06 | 2012-12-11 | Senorx, Inc. | Temporary catheter for biopsy site tissue fixation |
US20050015049A1 (en) * | 2003-07-16 | 2005-01-20 | Rioux Robert F. | Temporary tissue spacer and pretreatment balloon |
US20120289859A9 (en) * | 2003-08-27 | 2012-11-15 | Nicoson Zachary R | System and method for minimally invasive disease therapy |
US8172770B2 (en) | 2005-09-28 | 2012-05-08 | Suros Surgical Systems, Inc. | System and method for minimally invasive disease therapy |
WO2005067442A2 (en) * | 2003-09-03 | 2005-07-28 | Rubicor Medical, Inc. | Short term post surgical cavity treatment devices and methods |
US20050080313A1 (en) * | 2003-10-10 | 2005-04-14 | Stewart Daren L. | Applicator for radiation treatment of a cavity |
US7783006B2 (en) * | 2003-10-10 | 2010-08-24 | Xoft, Inc. | Radiation treatment using x-ray source |
EP1568397A1 (en) * | 2004-02-25 | 2005-08-31 | Acrostak Corp. | Balloon for brachytherapy and application of the balloon |
US7127033B2 (en) | 2004-02-28 | 2006-10-24 | Xoft, Inc. | Miniature x-ray tube cooling system |
DE102004013012B3 (en) * | 2004-03-16 | 2005-06-16 | Universitätsklinikum Schleswig-Holstein | Balloon catheter for minimally invasive heart surgery has outer suction membrane with gas permeable zone |
US20050240073A1 (en) * | 2004-04-26 | 2005-10-27 | Apffelstaedt Justus P | Devices and methods to conform and treat body cavities |
US7708751B2 (en) | 2004-05-21 | 2010-05-04 | Ethicon Endo-Surgery, Inc. | MRI biopsy device |
US8932233B2 (en) | 2004-05-21 | 2015-01-13 | Devicor Medical Products, Inc. | MRI biopsy device |
US9638770B2 (en) | 2004-05-21 | 2017-05-02 | Devicor Medical Products, Inc. | MRI biopsy apparatus incorporating an imageable penetrating portion |
US20060079727A1 (en) * | 2004-09-03 | 2006-04-13 | Rubicor Medical, Inc. | Short term post surgical cavity treatment devices and methods |
US7534202B2 (en) * | 2004-10-04 | 2009-05-19 | Board Of Regents, The University Of Texas System | System and method for high dose rate radiation intracavitary brachytherapy |
US7662082B2 (en) | 2004-11-05 | 2010-02-16 | Theragenics Corporation | Expandable brachytherapy device |
EP1681077A1 (en) * | 2005-01-12 | 2006-07-19 | Acrostak Corp. | A positioning device and a procedure for treating the walls of a resection cavity |
US8317725B2 (en) | 2005-08-05 | 2012-11-27 | Senorx, Inc. | Biopsy device with fluid delivery to tissue specimens |
US7572236B2 (en) | 2005-08-05 | 2009-08-11 | Senorx, Inc. | Biopsy device with fluid delivery to tissue specimens |
WO2007021776A2 (en) * | 2005-08-09 | 2007-02-22 | Board Of Regents, The University Of Texas System | Methods and devices for breast reconstruction |
US20080200834A1 (en) * | 2005-09-28 | 2008-08-21 | Mark Joseph L | Introducer device for improved imaging |
WO2007053823A2 (en) | 2005-10-31 | 2007-05-10 | Biolucent, Inc. | Brachytherapy apparatus and methods of using same |
US20070100368A1 (en) | 2005-10-31 | 2007-05-03 | Quijano Rodolfo C | Intragastric space filler |
US7862496B2 (en) | 2005-11-10 | 2011-01-04 | Cianna Medical, Inc. | Brachytherapy apparatus and methods for using them |
US7887476B2 (en) | 2005-11-10 | 2011-02-15 | Cianna Medical, Inc. | Helical brachytherapy apparatus and methods of using same |
US8079946B2 (en) | 2005-11-18 | 2011-12-20 | Senorx, Inc. | Asymmetrical irradiation of a body cavity |
US8273006B2 (en) * | 2005-11-18 | 2012-09-25 | Senorx, Inc. | Tissue irradiation |
US7517310B2 (en) * | 2005-11-18 | 2009-04-14 | Senorx, Inc. | Methods for tissue irradiation with shielding |
US7413539B2 (en) * | 2005-11-18 | 2008-08-19 | Senorx, Inc. | Treatment of a body cavity |
US20070119461A1 (en) * | 2005-11-18 | 2007-05-31 | Brian Biancucci | Article isolation device and methods |
US8137256B2 (en) | 2005-12-16 | 2012-03-20 | Portola Medical, Inc. | Brachytherapy apparatus |
US20070270627A1 (en) | 2005-12-16 | 2007-11-22 | North American Scientific | Brachytherapy apparatus for asymmetrical body cavities |
US20070219488A1 (en) * | 2005-12-16 | 2007-09-20 | Darius Francescatti | Active drainage system for use in defined natural or surgically created body cavities or lumina |
US20070173680A1 (en) * | 2005-12-29 | 2007-07-26 | Boston Scientific Scimed, Inc | Apparatus and method for performing therapeutic tissue ablation and brachytherapy |
WO2007106817A2 (en) * | 2006-03-14 | 2007-09-20 | Niyazi Beyhan | Methods and apparatus for imaging and treating hollow body cavities |
CN101045175B (en) * | 2006-03-29 | 2012-07-04 | 微创医疗器械(上海)有限公司 | Double-layered balloon catheter |
US20140025056A1 (en) * | 2006-05-24 | 2014-01-23 | Kambiz Dowlatshahi | Image-guided removal and thermal therapy of breast cancer |
WO2007140278A2 (en) * | 2006-05-24 | 2007-12-06 | Rush University Medical Center | High temperature thermal therapy of breast cancer |
US9072893B2 (en) | 2006-06-02 | 2015-07-07 | Cianna Medical, Inc. | Expandable brachytherapy apparatus and methods for using them |
AU2007307854B2 (en) * | 2006-10-08 | 2012-01-19 | Cianna Medical, Inc. | Expandable brachytherapy apparatus |
US7727137B2 (en) * | 2006-10-13 | 2010-06-01 | Xoft, Inc. | Balloon brachytherapy applicator and method |
US8012086B2 (en) * | 2006-10-19 | 2011-09-06 | Ethicon Endo-Surgery, Inc. | Sterile transcolonic access device |
US7357770B1 (en) | 2006-11-03 | 2008-04-15 | North American Scientific, Inc. | Expandable brachytherapy device with constant radiation source spacing |
WO2008058089A2 (en) | 2006-11-03 | 2008-05-15 | North American Scientific, Inc. | Brachytherapy device having seed tubes with individually-settable tissue spacings |
US20080146861A1 (en) * | 2006-12-18 | 2008-06-19 | Goshen Health System, Inc. | Brachytherapy Shielding System |
US7655004B2 (en) | 2007-02-15 | 2010-02-02 | Ethicon Endo-Surgery, Inc. | Electroporation ablation apparatus, system, and method |
US8287442B2 (en) * | 2007-03-12 | 2012-10-16 | Senorx, Inc. | Radiation catheter with multilayered balloon |
US20080228023A1 (en) * | 2007-03-15 | 2008-09-18 | Senorx, Inc. | Soft body catheter with low friction lumen |
US8740873B2 (en) * | 2007-03-15 | 2014-06-03 | Hologic, Inc. | Soft body catheter with low friction lumen |
US8226602B2 (en) * | 2007-03-30 | 2012-07-24 | Reshape Medical, Inc. | Intragastric balloon system and therapeutic processes and products |
US8423152B2 (en) * | 2007-05-14 | 2013-04-16 | Bsd Medical Corporation | Apparatus and method for selectively heating a deposit in fatty tissue in a body |
US20090306646A1 (en) * | 2007-05-14 | 2009-12-10 | Bsd Medical Corporation | Apparatus and method for injection enhancement of selective heating of a deposit in tissues in a body |
US9387036B2 (en) * | 2007-05-14 | 2016-07-12 | Pyrexar Medical Inc. | Apparatus and method for selectively heating a deposit in fatty tissue in a body |
US20080300571A1 (en) * | 2007-05-30 | 2008-12-04 | Lepivert Patrick | Process and device for selectively treating interstitial tissue |
US8114005B2 (en) * | 2007-06-04 | 2012-02-14 | Xoft, Inc. | Method for modifying skin distance from a brachytherapy balloon applicator |
US8142469B2 (en) * | 2007-06-25 | 2012-03-27 | Reshape Medical, Inc. | Gastric space filler device, delivery system, and related methods |
US7771340B2 (en) * | 2007-07-28 | 2010-08-10 | Xoft, Inc. | Method and apparatus for modifying distance from a brachytherapy radiation source to sensitive anatomical structures |
US8202229B2 (en) | 2007-10-01 | 2012-06-19 | Suros Surgical Systems, Inc. | Surgical device |
US8808200B2 (en) | 2007-10-01 | 2014-08-19 | Suros Surgical Systems, Inc. | Surgical device and method of using same |
US8409070B2 (en) * | 2007-10-26 | 2013-04-02 | Xoft, Inc. | Brachytherapy apparatus and method for use with minimally invasive surgeries of the lung |
US20090143728A1 (en) * | 2007-11-30 | 2009-06-04 | Numed, Inc. | Balloon catheter with safety feature |
US8517907B2 (en) | 2007-12-16 | 2013-08-27 | Cianna Medical, Inc. | Expandable brachytherapy apparatus and methods for using them |
US8360950B2 (en) * | 2008-01-24 | 2013-01-29 | Senorx, Inc. | Multilumen brachytherapy balloon catheter |
WO2009108909A1 (en) * | 2008-02-29 | 2009-09-03 | Vivaray, Inc. | Systems and methods for delivering radiation therapy |
US20100010287A1 (en) * | 2008-07-09 | 2010-01-14 | Senorx, Inc. | Brachytherapy device with one or more toroidal balloons |
US8888792B2 (en) | 2008-07-14 | 2014-11-18 | Ethicon Endo-Surgery, Inc. | Tissue apposition clip application devices and methods |
US8636635B2 (en) | 2008-08-18 | 2014-01-28 | Cianna Medical, Inc. | Brachytherapy apparatus, systems, and methods for using them |
US8500618B2 (en) * | 2008-09-11 | 2013-08-06 | Radiadyne, Llc | Dual gynecological balloon packing system |
US20100094074A1 (en) * | 2008-10-10 | 2010-04-15 | Hologic Inc. | Brachytherapy apparatus and methods employing expandable medical devices comprising fixation elements |
US8157834B2 (en) | 2008-11-25 | 2012-04-17 | Ethicon Endo-Surgery, Inc. | Rotational coupling device for surgical instrument with flexible actuators |
DE102008060162A1 (en) * | 2008-12-02 | 2010-06-10 | Carl Zeiss Surgical Gmbh | Balloon catheter and applicator with balloon catheter |
US8361066B2 (en) | 2009-01-12 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US9579524B2 (en) | 2009-02-11 | 2017-02-28 | Hologic, Inc. | Flexible multi-lumen brachytherapy device |
US9248311B2 (en) | 2009-02-11 | 2016-02-02 | Hologic, Inc. | System and method for modifying a flexibility of a brachythereapy catheter |
US8845582B2 (en) * | 2009-03-09 | 2014-09-30 | Flip Technologies Limited | Device for protecting a catheter, and a method for locating a catheter in a remote location in a human or animal body |
US9174031B2 (en) * | 2009-03-13 | 2015-11-03 | Reshape Medical, Inc. | Device and method for deflation and removal of implantable and inflatable devices |
US8683881B2 (en) * | 2009-04-03 | 2014-04-01 | Reshape Medical, Inc. | Intragastric space fillers and methods of manufacturing including in vitro testing |
US10207126B2 (en) | 2009-05-11 | 2019-02-19 | Cytyc Corporation | Lumen visualization and identification system for multi-lumen balloon catheter |
US8663210B2 (en) | 2009-05-13 | 2014-03-04 | Novian Health, Inc. | Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy |
US8033995B2 (en) * | 2009-06-05 | 2011-10-11 | Ethicon Endo-Surgery, Inc. | Inflatable retractor with insufflation and method |
US20100331878A1 (en) * | 2009-06-25 | 2010-12-30 | Carl Zeiss Surgical Gmbh | Method and device for removing a balloon from a body cavity |
WO2011011629A2 (en) | 2009-07-22 | 2011-01-27 | Reshape Medical, Inc. | Retrieval mechanisms for implantable medical devices |
US9050174B2 (en) | 2009-07-23 | 2015-06-09 | Reshape Medical, Inc. | Deflation and removal of implantable medical devices |
WO2011011741A2 (en) | 2009-07-23 | 2011-01-27 | Reshape Medical, Inc. | Inflation and deflation mechanisms for inflatable medical devices |
WO2011038270A2 (en) | 2009-09-24 | 2011-03-31 | Reshape Medical, Inc. | Normalization and stabilization of balloon surfaces for deflation |
US20110098704A1 (en) | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US9028483B2 (en) | 2009-12-18 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US10016620B2 (en) | 2010-02-04 | 2018-07-10 | Procept Biorobotics Incorporation | Tissue sampling and cancer treatment apparatus |
EP2533845A4 (en) | 2010-02-08 | 2016-04-06 | Reshape Medical Inc | Improved and enhanced aspiration processes and mechanisms for intragastric devices |
EP2533846B1 (en) | 2010-02-08 | 2018-08-22 | ReShape Medical LLC | Materials and methods for improved intragastric balloon devices |
US9642999B2 (en) | 2010-02-12 | 2017-05-09 | Varian Medical Systems, Inc. | Brachytherapy applicator |
EP2539011A4 (en) | 2010-02-25 | 2014-03-26 | Reshape Medical Inc | Improved and enhanced explant processes and mechanisms for intragastric devices |
US8814775B2 (en) | 2010-03-18 | 2014-08-26 | Cianna Medical, Inc. | Expandable brachytherapy apparatus and methods for using them |
EP2555705A4 (en) | 2010-04-06 | 2014-01-15 | Reshape Medical Inc | Inflation devices for intragastric devices with improved attachment and detachment and associated systems and methods |
US9883919B2 (en) | 2010-07-21 | 2018-02-06 | Cianna Medical, Inc. | Brachytherapy apparatus, systems, and methods for using them |
US10589071B2 (en) | 2010-09-23 | 2020-03-17 | Best Medical International, Inc. | Multiple function balloon catheter |
US9402980B2 (en) | 2010-09-23 | 2016-08-02 | Best Medical International, Inc. | Rectal catheter for urological and other applications |
US10744307B2 (en) | 2010-09-23 | 2020-08-18 | Best Medical International, Inc. | Multi-purpose balloon catheter for intra cavity radiation delivery |
US9352172B2 (en) | 2010-09-30 | 2016-05-31 | Hologic, Inc. | Using a guide member to facilitate brachytherapy device swap |
US9067063B2 (en) | 2010-11-03 | 2015-06-30 | Cianna Medical, Inc. | Expandable brachytherapy apparatus and methods for using them |
US20120150107A1 (en) * | 2010-12-14 | 2012-06-14 | Boston Scientific Scimed, Inc. | Balloon catheter shafts and methods of manufacturing |
WO2012096787A1 (en) * | 2010-12-30 | 2012-07-19 | Surmodics, Inc. | Double wall catheter for delivering therapeutic agent |
US9498644B2 (en) | 2011-01-03 | 2016-11-22 | Best Medical International, Inc. | Apparatus for brachytherapy |
US9283402B2 (en) * | 2011-01-03 | 2016-03-15 | Best Medical International, Inc. | Apparatus and method for providing a double balloon breast brachytherapy device |
US10342992B2 (en) | 2011-01-06 | 2019-07-09 | Hologic, Inc. | Orienting a brachytherapy applicator |
US9233241B2 (en) | 2011-02-28 | 2016-01-12 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9254169B2 (en) | 2011-02-28 | 2016-02-09 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US10898693B2 (en) | 2011-03-01 | 2021-01-26 | Sanovas Intellectual Property, Llc | Nasal delivery of agents with nested balloon catheter |
US8348890B2 (en) * | 2011-03-01 | 2013-01-08 | Sanovas, Inc. | Nested balloon catheter for localized drug delivery |
US8932251B2 (en) | 2011-03-10 | 2015-01-13 | Western New England University | Biopsy spacer device and method of operation |
US10201688B2 (en) | 2011-03-10 | 2019-02-12 | Western New England University | Biopsy spacer device and method of operation |
US9049987B2 (en) | 2011-03-17 | 2015-06-09 | Ethicon Endo-Surgery, Inc. | Hand held surgical device for manipulating an internal magnet assembly within a patient |
US9180281B2 (en) * | 2011-04-08 | 2015-11-10 | Sanovas, Inc. | Adjustable balloon catheter for extravasated drug delivery |
US20130090666A1 (en) * | 2011-10-06 | 2013-04-11 | Ethicon Endo-Surgery, Inc. | Vacuum assisted tissue manipulation devices and surgical methods |
US9113879B2 (en) | 2011-12-15 | 2015-08-25 | Ethicon Endo-Surgery, Inc. | Devices and methods for endoluminal plication |
US9113866B2 (en) | 2011-12-15 | 2015-08-25 | Ethicon Endo-Surgery, Inc. | Devices and methods for endoluminal plication |
US8992547B2 (en) | 2012-03-21 | 2015-03-31 | Ethicon Endo-Surgery, Inc. | Methods and devices for creating tissue plications |
US9427255B2 (en) | 2012-05-14 | 2016-08-30 | Ethicon Endo-Surgery, Inc. | Apparatus for introducing a steerable camera assembly into a patient |
US9078662B2 (en) | 2012-07-03 | 2015-07-14 | Ethicon Endo-Surgery, Inc. | Endoscopic cap electrode and method for using the same |
US9545290B2 (en) | 2012-07-30 | 2017-01-17 | Ethicon Endo-Surgery, Inc. | Needle probe guide |
US10314649B2 (en) | 2012-08-02 | 2019-06-11 | Ethicon Endo-Surgery, Inc. | Flexible expandable electrode and method of intraluminal delivery of pulsed power |
US9572623B2 (en) | 2012-08-02 | 2017-02-21 | Ethicon Endo-Surgery, Inc. | Reusable electrode and disposable sheath |
US9277957B2 (en) | 2012-08-15 | 2016-03-08 | Ethicon Endo-Surgery, Inc. | Electrosurgical devices and methods |
US10098527B2 (en) | 2013-02-27 | 2018-10-16 | Ethidcon Endo-Surgery, Inc. | System for performing a minimally invasive surgical procedure |
WO2015179631A1 (en) * | 2014-05-21 | 2015-11-26 | The Regents Of The University Of Michigan | Fenestrated decoupling system for internal selective attachment to soft tissue organs |
ES2726670T3 (en) * | 2014-05-21 | 2019-10-08 | Univ Michigan Regents | Fenestrated decoupling system for selective internal fixation to soft tissue organs |
CN106659868B (en) * | 2014-06-24 | 2019-11-29 | 普罗赛普特生物机器人公司 | Sample of tissue and cancer treatment facilities |
CN104436421B (en) * | 2014-11-28 | 2017-12-01 | 刘宗军 | One kind can dabbling drug sacculus |
US10117738B2 (en) | 2015-01-23 | 2018-11-06 | The Regents Of The University Of Michigan | Atraumatic tip geometry for indwelling devices |
US10342611B2 (en) * | 2015-04-29 | 2019-07-09 | Innoblative Designs, Inc. | Cavitary tissue ablation |
CN108495582B (en) | 2015-09-03 | 2020-10-02 | 海王星医疗公司 | Instrument for advancing an endoscope through the small intestine |
EP3367945B1 (en) | 2015-10-29 | 2020-02-26 | Innoblative Designs, Inc. | Screen sphere tissue ablation devices |
WO2017136261A1 (en) | 2016-02-02 | 2017-08-10 | Innoblative Designs, Inc. | Cavitary tissue ablation system |
WO2017151431A1 (en) | 2016-03-01 | 2017-09-08 | Innoblative Designs, Inc. | Resecting and coagulating tissue |
US20160206296A1 (en) * | 2016-03-25 | 2016-07-21 | Hamid Ehsani-Nia | Biopsy Syringe Device |
CN110191667B (en) | 2016-08-18 | 2022-06-03 | 海王星医疗公司 | Device and method for enhancing the visual effects of the small intestine |
WO2018075389A1 (en) | 2016-10-17 | 2018-04-26 | Innoblative Designs, Inc. | Treatment devices and methods |
JP6875757B2 (en) | 2016-11-08 | 2021-05-26 | イノブレイティブ デザインズ, インコーポレイテッド | Electrosurgical tissue and vascular seal device |
EP3658053B1 (en) | 2017-07-26 | 2023-09-13 | Innoblative Designs, Inc. | Minimally invasive articulating assembly having ablation capabilities |
JP2021531111A (en) | 2018-07-19 | 2021-11-18 | ネプチューン メディカル インク. | Dynamic hardening medical composite structure |
CN113301948B (en) * | 2019-01-10 | 2023-06-30 | 奥林巴斯株式会社 | Phototherapy device |
US11793392B2 (en) | 2019-04-17 | 2023-10-24 | Neptune Medical Inc. | External working channels |
US11383093B1 (en) | 2019-12-06 | 2022-07-12 | Hoseon LEE | Radiation release capsule |
CN110975175B (en) * | 2020-01-06 | 2021-12-07 | 温州市中心医院 | Radiation therapy protector in gynaecology's tumour intracavity |
EP4126095A1 (en) | 2020-03-30 | 2023-02-08 | Neptune Medical Inc. | Layered walls for rigidizing devices |
CN111569277B (en) * | 2020-05-13 | 2022-02-18 | 戴建荣 | Radiotherapy target region separator |
EP4333746A1 (en) * | 2021-05-04 | 2024-03-13 | Hemosquid | Hemostatic device |
EP4085855A1 (en) * | 2021-05-04 | 2022-11-09 | Hemosquid | Hemostatic device |
WO2023081072A1 (en) * | 2021-11-05 | 2023-05-11 | Cook Medical Technologies Llc | Uterine tamponade device |
US20230346205A1 (en) | 2022-04-27 | 2023-11-02 | Neptune Medical Inc. | Multi-lumen port adapter manifold devices and methods of use |
Family Cites Families (156)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3324847A (en) | 1964-06-01 | 1967-06-13 | Elias G Zoumboulis | Radioactive catheter |
US3872856A (en) | 1971-06-09 | 1975-03-25 | Ralph S Clayton | Apparatus for treating the walls and floor of the pelvic cavity with radiation |
US3975350A (en) * | 1972-08-02 | 1976-08-17 | Princeton Polymer Laboratories, Incorporated | Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles |
US4119094A (en) * | 1977-08-08 | 1978-10-10 | Biosearch Medical Products Inc. | Coated substrate having a low coefficient of friction hydrophilic coating and a method of making the same |
US4454106A (en) * | 1982-06-07 | 1984-06-12 | Gansow Otto A | Use of metal chelate conjugated monoclonal antibodies |
US4571241A (en) * | 1983-12-16 | 1986-02-18 | Christopher T Graham | Urinary catheter with collapsible urethral tube |
US4690677A (en) | 1985-09-25 | 1987-09-01 | Daltex Medical Sciences, Inc. | Urine collection system for females |
US4763642A (en) * | 1986-04-07 | 1988-08-16 | Horowitz Bruce S | Intracavitational brachytherapy |
JPS6446056U (en) | 1987-09-17 | 1989-03-22 | ||
US4998917A (en) * | 1988-05-26 | 1991-03-12 | Advanced Cardiovascular Systems, Inc. | High torque steerable dilatation catheter |
US5227969A (en) * | 1988-08-01 | 1993-07-13 | W. L. Systems, Inc. | Manipulable three-dimensional projection imaging method |
US4998930A (en) * | 1988-08-03 | 1991-03-12 | Phototherapeutic Systems | Intracavity laser phototherapy method |
US4929470A (en) * | 1989-02-24 | 1990-05-29 | James River Corporation | Method of making decorative cast-coated paper |
US5312356A (en) * | 1989-05-22 | 1994-05-17 | Target Therapeutics | Catheter with low-friction distal segment |
US5535817A (en) * | 1989-07-28 | 1996-07-16 | Uop | Sorption cooling process and apparatus |
US5059166A (en) * | 1989-12-11 | 1991-10-22 | Medical Innovative Technologies R & D Limited Partnership | Intra-arterial stent with the capability to inhibit intimal hyperplasia |
US5439446A (en) * | 1994-06-30 | 1995-08-08 | Boston Scientific Corporation | Stent and therapeutic delivery system |
DE3941705C2 (en) * | 1989-12-18 | 1994-10-13 | Gsf Forschungszentrum Umwelt | Device for the isotropic irradiation of cavities of spherical shape |
US5199939B1 (en) * | 1990-02-23 | 1998-08-18 | Michael D Dake | Radioactive catheter |
US5422926A (en) | 1990-09-05 | 1995-06-06 | Photoelectron Corporation | X-ray source with shaped radiation pattern |
US5167622A (en) * | 1990-12-07 | 1992-12-01 | Smiths Industries Medical Systems, Inc. | Triple conduit suction catheter |
US5931774A (en) | 1991-06-14 | 1999-08-03 | Proxima Therapeutics, Inc. | Inflatable devices for tumor treatment |
US5429582A (en) | 1991-06-14 | 1995-07-04 | Williams; Jeffery A. | Tumor treatment |
AU649845B2 (en) * | 1991-06-24 | 1994-06-02 | Sumitomo Electric Industries, Ltd. | Method for producing glass preform for optical fiber |
US5766151A (en) | 1991-07-16 | 1998-06-16 | Heartport, Inc. | Endovascular system for arresting the heart |
US5302168A (en) * | 1991-09-05 | 1994-04-12 | Hess Robert L | Method and apparatus for restenosis treatment |
EP0536440B1 (en) * | 1991-10-11 | 1997-05-28 | Erbe Elektromedizin GmbH | H.F. surgical instrument for cutting and coagulating |
US5431662A (en) | 1992-02-12 | 1995-07-11 | United States Surgical Corporation | Manipulator apparatus |
US5259847A (en) * | 1992-06-25 | 1993-11-09 | Montefiore Hospital And Medical Center | Catheter to maintain minimally invasive access for exchanging internal biliary stents |
US6623516B2 (en) * | 1992-08-13 | 2003-09-23 | Mark A. Saab | Method for changing the temperature of a selected body region |
US5342305A (en) | 1992-08-13 | 1994-08-30 | Cordis Corporation | Variable distention angioplasty balloon assembly |
US5417687A (en) | 1993-04-30 | 1995-05-23 | Medical Scientific, Inc. | Bipolar electrosurgical trocar |
US5381504A (en) * | 1993-11-15 | 1995-01-10 | Minnesota Mining And Manufacturing Company | Optical fiber element having a permanent protective coating with a Shore D hardness value of 65 or more |
US5503613A (en) * | 1994-01-21 | 1996-04-02 | The Trustees Of Columbia University In The City Of New York | Apparatus and method to reduce restenosis after arterial intervention |
US5538510A (en) * | 1994-01-31 | 1996-07-23 | Cordis Corporation | Catheter having coextruded tubing |
US5670558A (en) | 1994-07-07 | 1997-09-23 | Terumo Kabushiki Kaisha | Medical instruments that exhibit surface lubricity when wetted |
ATE207651T1 (en) | 1994-07-12 | 2001-11-15 | Photoelectron Corp | X-RAY DEVICE FOR DOSING A PREDETERMINED FLOW OF RADIATION TO INNER SURFACES OF BODY CAVIES |
US5566221A (en) * | 1994-07-12 | 1996-10-15 | Photoelectron Corporation | Apparatus for applying a predetermined x-radiation flux to an interior surface of a body cavity |
US5899882A (en) * | 1994-10-27 | 1999-05-04 | Novoste Corporation | Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient |
ES2181802T3 (en) * | 1994-11-23 | 2003-03-01 | Micro Interventional Systems I | BALLOON CATHETER WITH STRONG TORSION. |
AU4242996A (en) * | 1994-11-23 | 1996-06-17 | Navarre Biomedical, Ltd. | Flexible catheter |
US5616114A (en) * | 1994-12-08 | 1997-04-01 | Neocardia, Llc. | Intravascular radiotherapy employing a liquid-suspended source |
DE69534275T2 (en) | 1994-12-27 | 2006-03-23 | Olympus Optical Co., Ltd. | Medical device |
US5653683A (en) * | 1995-02-28 | 1997-08-05 | D'andrea; Mark A. | Intracavitary catheter for use in therapeutic radiation procedures |
JP2865428B2 (en) * | 1995-04-28 | 1999-03-08 | ターゲット セラピューティクス, インコーポレイテッド | High performance braided catheter |
JPH11504829A (en) * | 1995-05-05 | 1999-05-11 | アドバンスト・カーディオバスキュラー・システムズ・インコーポレイテッド | In-pipe device with anti-friction surface |
US6256529B1 (en) | 1995-07-26 | 2001-07-03 | Burdette Medical Systems, Inc. | Virtual reality 3D visualization for surgical procedures |
US5603991A (en) * | 1995-09-29 | 1997-02-18 | Target Therapeutics, Inc. | Method for coating catheter lumens |
KR19990064070A (en) | 1995-10-06 | 1999-07-26 | 피터 이. 외팅거 | X-ray irradiation device inside the body cavity |
US5840008A (en) * | 1995-11-13 | 1998-11-24 | Localmed, Inc. | Radiation emitting sleeve catheter and methods |
IL125259A (en) * | 1996-01-08 | 2002-12-01 | Biosense Inc | Apparatus for myocardial revascularization |
EP0877636B1 (en) * | 1996-01-31 | 2002-10-02 | E.I. Du Pont De Nemours And Company | Dilatation catheter balloons with improved puncture resistance |
US5855546A (en) | 1996-02-29 | 1999-01-05 | Sci-Med Life Systems | Perfusion balloon and radioactive wire delivery system |
US5916143A (en) * | 1996-04-30 | 1999-06-29 | Apple; Marc G. | Brachytherapy catheter system |
US6235037B1 (en) | 1996-05-24 | 2001-05-22 | West-Walker Bennett | Surgical apparatus |
US5993972A (en) * | 1996-08-26 | 1999-11-30 | Tyndale Plains-Hunter, Ltd. | Hydrophilic and hydrophobic polyether polyurethanes and uses therefor |
US5924973A (en) * | 1996-09-26 | 1999-07-20 | The Trustees Of Columbia University In The City Of New York | Method of treating a disease process in a luminal structure |
IT1288728B1 (en) * | 1996-10-04 | 1998-09-24 | Bridgestone Firestone Tech | METALLIC HEEL FOR TIRES AND METHOD FOR ITS REALIZATION. |
JP3810157B2 (en) * | 1996-11-07 | 2006-08-16 | オリンパス株式会社 | Suction biopsy tool |
US5935098A (en) | 1996-12-23 | 1999-08-10 | Conceptus, Inc. | Apparatus and method for accessing and manipulating the uterus |
US5879282A (en) | 1997-01-21 | 1999-03-09 | Cordis A Johnson And Johnson Company | Catheter having an expandable radioactive source |
US5863285A (en) | 1997-01-30 | 1999-01-26 | Cordis Corporation | Balloon catheter with radioactive means |
US6458069B1 (en) | 1998-02-19 | 2002-10-01 | Endology, Inc. | Multi layer radiation delivery balloon |
US5782742A (en) * | 1997-01-31 | 1998-07-21 | Cardiovascular Dynamics, Inc. | Radiation delivery balloon |
DE69823406T2 (en) * | 1997-02-21 | 2005-01-13 | Medtronic AVE, Inc., Santa Rosa | X-ray device provided with a strain structure for local irradiation of the interior of a body |
US6770058B1 (en) * | 1997-03-11 | 2004-08-03 | Interventional Therapies, Llc | Treatment catheter insert |
US6033357A (en) | 1997-03-28 | 2000-03-07 | Navius Corporation | Intravascular radiation delivery device |
US5868708A (en) * | 1997-05-07 | 1999-02-09 | Applied Medical Resources Corporation | Balloon catheter apparatus and method |
US5919473A (en) * | 1997-05-12 | 1999-07-06 | Elkhoury; George F. | Methods and devices for delivering opioid analgesics to wounds via a subdermal implant |
US5918813A (en) | 1997-06-17 | 1999-07-06 | Rucker; David L. | Rotating spray head |
US6482142B1 (en) | 1997-07-24 | 2002-11-19 | Proxima Therapeutics, Inc. | Asymmetric radiation dosing apparatus and method |
US5913813A (en) | 1997-07-24 | 1999-06-22 | Proxima Therapeutics, Inc. | Double-wall balloon catheter for treatment of proliferative tissue |
JP2001515773A (en) * | 1997-09-11 | 2001-09-25 | クック インコーポレイティド | Medical radiotherapy drug injection device |
US6019922A (en) * | 1997-10-01 | 2000-02-01 | Johnson & Johnson Mfg Sn Bhd | Powder-free medical gloves |
AU4318499A (en) | 1997-11-24 | 1999-12-13 | Burdette Medical Systems, Inc. | Real time brachytherapy spatial registration and visualization system |
US6129670A (en) * | 1997-11-24 | 2000-10-10 | Burdette Medical Systems | Real time brachytherapy spatial registration and visualization system |
US5997462A (en) | 1998-01-08 | 1999-12-07 | Delft Instruments Intellectual Property B.V. | Method and apparatus for treating a blood vessel lesion |
JP4345229B2 (en) | 1998-01-30 | 2009-10-14 | 株式会社カネカ | Balloon catheter and catheter shaft and balloon manufacturing method used therefor |
US6036631A (en) | 1998-03-09 | 2000-03-14 | Urologix, Inc. | Device and method for intracavitary cancer treatment |
US6905494B2 (en) * | 1998-03-31 | 2005-06-14 | Innercool Therapies, Inc. | Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection |
US6086970A (en) * | 1998-04-28 | 2000-07-11 | Scimed Life Systems, Inc. | Lubricious surface extruded tubular members for medical devices |
US6093142A (en) * | 1998-04-30 | 2000-07-25 | Medtronic Inc. | Device for in vivo radiation delivery and method for delivery |
US6217565B1 (en) * | 1998-07-16 | 2001-04-17 | Mark Cohen | Reinforced variable stiffness tubing |
US7967855B2 (en) | 1998-07-27 | 2011-06-28 | Icon Interventional Systems, Inc. | Coated medical device |
US7276063B2 (en) | 1998-08-11 | 2007-10-02 | Arthrocare Corporation | Instrument for electrosurgical tissue treatment |
US6413203B1 (en) | 1998-09-16 | 2002-07-02 | Scimed Life Systems, Inc. | Method and apparatus for positioning radioactive fluids within a body lumen |
US7141246B2 (en) | 1998-10-07 | 2006-11-28 | Sherwood Services Ag | Lubricious coating |
US6645483B2 (en) * | 1998-10-07 | 2003-11-11 | Sherwood Services Ag | Lubricious coating |
US6605030B2 (en) * | 1998-11-09 | 2003-08-12 | The Trustees Of Columbia University In The City Of New York | Apparatus and method for treating a disease process in a luminal structure |
US6200257B1 (en) * | 1999-03-24 | 2001-03-13 | Proxima Therapeutics, Inc. | Catheter with permeable hydrogel membrane |
US6319188B1 (en) * | 1999-04-26 | 2001-11-20 | Xoft Microtube, Inc. | Vascular X-ray probe |
US6464625B2 (en) | 1999-06-23 | 2002-10-15 | Robert A. Ganz | Therapeutic method and apparatus for debilitating or killing microorganisms within the body |
US6251060B1 (en) | 1999-07-23 | 2001-06-26 | Nucletron B.V. | Apparatus and method for temporarily inserting a radioactive source in an animal body |
US6575966B2 (en) | 1999-08-23 | 2003-06-10 | Cryocath Technologies Inc. | Endovascular cryotreatment catheter |
US6610013B1 (en) * | 1999-10-01 | 2003-08-26 | Life Imaging Systems, Inc. | 3D ultrasound-guided intraoperative prostate brachytherapy |
JP2001110181A (en) * | 1999-10-13 | 2001-04-20 | Oki Electric Ind Co Ltd | Semiconductor memory |
JP4445617B2 (en) * | 1999-10-27 | 2010-04-07 | オリンパス株式会社 | Endoscopic treatment tool |
US20030144570A1 (en) * | 1999-11-12 | 2003-07-31 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
AU1374601A (en) * | 1999-11-12 | 2001-05-30 | Angiotech International Ag | Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
US7109505B1 (en) | 2000-02-11 | 2006-09-19 | Carl Zeiss Ag | Shaped biocompatible radiation shield and method for making same |
US6615070B2 (en) | 2000-06-01 | 2003-09-02 | Georgia Tech Research Corporation | Automated planning volume contouring algorithm for adjuvant brachytherapy treatment planning in sarcoma |
US6390968B1 (en) * | 2000-06-07 | 2002-05-21 | Paxton Equities, Llc | Cervical applicator for high dose radiation brachytherapy |
JP2002017774A (en) * | 2000-07-05 | 2002-01-22 | Olympus Optical Co Ltd | Microwave therapeutic device |
EP1304965A2 (en) | 2000-07-31 | 2003-05-02 | Boston Scientific Limited | Expandable atherectomy burr |
US6390967B1 (en) | 2000-09-14 | 2002-05-21 | Xoft Microtube, Inc. | Radiation for inhibiting hyperplasia after intravascular intervention |
US6416492B1 (en) | 2000-09-28 | 2002-07-09 | Scimed Life Systems, Inc. | Radiation delivery system utilizing intravascular ultrasound |
US6540720B1 (en) | 2000-11-10 | 2003-04-01 | Scimed Life Systems, Inc. | Miniature x-ray unit |
US6554757B1 (en) | 2000-11-10 | 2003-04-29 | Scimed Life Systems, Inc. | Multi-source x-ray catheter |
US6540655B1 (en) | 2000-11-10 | 2003-04-01 | Scimed Life Systems, Inc. | Miniature x-ray unit |
US7179251B2 (en) | 2001-01-17 | 2007-02-20 | Boston Scientific Scimed, Inc. | Therapeutic delivery balloon |
US6527693B2 (en) | 2001-01-30 | 2003-03-04 | Implant Sciences Corporation | Methods and implants for providing radiation to a patient |
US6723052B2 (en) * | 2001-06-07 | 2004-04-20 | Stanley L. Mills | Echogenic medical device |
US6673006B2 (en) | 2001-06-15 | 2004-01-06 | Proxima Therapeutics, Inc. | Tissue positioning apparatus and method for protecting tissue from radiotherapy |
US6746392B2 (en) | 2001-06-20 | 2004-06-08 | Medtronic Ave, Inc. | Brachytherapy catheter with twisted lumens and methods of use |
US6746465B2 (en) | 2001-12-14 | 2004-06-08 | The Regents Of The University Of California | Catheter based balloon for therapy modification and positioning of tissue |
US20040039437A1 (en) * | 2002-08-13 | 2004-02-26 | Medtronic, Inc. | Medical device exhibiting improved adhesion between polymeric coating and substrate |
US6758069B2 (en) * | 2002-08-30 | 2004-07-06 | Acco Brands, Inc. | Computer physical security devices |
DE60324448D1 (en) | 2002-09-10 | 2008-12-11 | Cianna Medical Inc | brachytherapy |
EP1541188B1 (en) | 2002-09-20 | 2011-07-06 | I.S.T. Corporation | Medical guide wire and process for production thereof |
EP1402922B1 (en) | 2002-09-27 | 2007-02-07 | Nucletron B.V. | Device for radiation treatment of proliferative tissue surrounding a cavity in an animal body |
JP2004121553A (en) * | 2002-10-02 | 2004-04-22 | Terumo Corp | Thermotherapeutic instrument |
US6983754B1 (en) | 2002-10-11 | 2006-01-10 | Anderson Randy M | Bag washing apparatus and method |
US6923754B2 (en) * | 2002-11-06 | 2005-08-02 | Senorx, Inc. | Vacuum device and method for treating tissue adjacent a body cavity |
US7267649B2 (en) * | 2003-01-24 | 2007-09-11 | Proteus Biomedical, Inc. | Method and system for remote hemodynamic monitoring |
US7098463B2 (en) | 2003-03-03 | 2006-08-29 | Heuris Pharma, Llc | Three-dimensional dosimeter for penetrating radiation and method of use |
US7513861B2 (en) | 2003-06-18 | 2009-04-07 | Xoft, Inc. | Real time verification in radiation treatment |
US7322929B2 (en) | 2003-06-18 | 2008-01-29 | Xoft, Inc. | Method for radiation treatment |
US7338430B2 (en) | 2003-06-18 | 2008-03-04 | Xoft, Inc. | Gynecological brachytherapy applicator and system |
US7578780B2 (en) | 2003-06-18 | 2009-08-25 | Xoft, Inc. | Brachytherapy applicator for delivery and assessment of low-level ionizing radiation therapy and methods of use |
WO2005067442A2 (en) | 2003-09-03 | 2005-07-28 | Rubicor Medical, Inc. | Short term post surgical cavity treatment devices and methods |
US7744587B2 (en) * | 2003-09-22 | 2010-06-29 | Boston Scientific Scimed, Inc. | Surface modified reinforcing member for medical device and method for making same |
US7783006B2 (en) | 2003-10-10 | 2010-08-24 | Xoft, Inc. | Radiation treatment using x-ray source |
US20050080313A1 (en) | 2003-10-10 | 2005-04-14 | Stewart Daren L. | Applicator for radiation treatment of a cavity |
US7438875B2 (en) | 2003-10-16 | 2008-10-21 | Kimberly-Clark Worldwide, Inc. | Method for reducing odor using metal-modified silica particles |
CA2536041A1 (en) | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
US20050124843A1 (en) | 2003-12-09 | 2005-06-09 | Washington University | Method and apparatus for delivering targeted therapy to a patient |
WO2005065761A2 (en) | 2003-12-31 | 2005-07-21 | C. R. Bard, Inc. | Reinforced multi-lumen catheter |
US20050240073A1 (en) | 2004-04-26 | 2005-10-27 | Apffelstaedt Justus P | Devices and methods to conform and treat body cavities |
GB2415907A (en) | 2004-07-05 | 2006-01-11 | Vishnu Shanker Shukla | A radiotherapy device for treating cancers in viscous organs such as the bladder |
EP1618924B1 (en) | 2004-07-20 | 2009-09-09 | Nucletron B.V. | Device for radiation treatment of proliferative tissue surrounding a cavity in an animal body |
US7850675B2 (en) | 2004-07-20 | 2010-12-14 | Boston Scientific Scimed, Inc. | Reinforced venous access catheter |
US7534202B2 (en) | 2004-10-04 | 2009-05-19 | Board Of Regents, The University Of Texas System | System and method for high dose rate radiation intracavitary brachytherapy |
US7662082B2 (en) | 2004-11-05 | 2010-02-16 | Theragenics Corporation | Expandable brachytherapy device |
JP4874259B2 (en) | 2004-11-23 | 2012-02-15 | ヌームアールエックス・インコーポレーテッド | Steerable device for accessing the target site |
CN101282760A (en) | 2005-08-11 | 2008-10-08 | 纳沃特克医药有限公司 | Medical treatment system and method using radioactivity based position sensor |
US20070049786A1 (en) | 2005-08-30 | 2007-03-01 | Cytyc Corporation | Safety-link brachytherapy catheter |
US7862496B2 (en) | 2005-11-10 | 2011-01-04 | Cianna Medical, Inc. | Brachytherapy apparatus and methods for using them |
US7887476B2 (en) | 2005-11-10 | 2011-02-15 | Cianna Medical, Inc. | Helical brachytherapy apparatus and methods of using same |
US20070270627A1 (en) | 2005-12-16 | 2007-11-22 | North American Scientific | Brachytherapy apparatus for asymmetrical body cavities |
US9072893B2 (en) | 2006-06-02 | 2015-07-07 | Cianna Medical, Inc. | Expandable brachytherapy apparatus and methods for using them |
EP2465439A1 (en) | 2006-08-14 | 2012-06-20 | Volcano Corporation | Imaging device, imaging system, and methods of imaging |
US20080057298A1 (en) | 2006-08-29 | 2008-03-06 | Surmodics, Inc. | Low friction particulate coatings |
AU2007307854B2 (en) | 2006-10-08 | 2012-01-19 | Cianna Medical, Inc. | Expandable brachytherapy apparatus |
US20080221444A1 (en) | 2007-03-07 | 2008-09-11 | Ritchie Paul G | Integrated Imaging and Biopsy System with Integrated Surgical, Therapy, and Diagnostic Devices |
US8740873B2 (en) | 2007-03-15 | 2014-06-03 | Hologic, Inc. | Soft body catheter with low friction lumen |
US8360950B2 (en) | 2008-01-24 | 2013-01-29 | Senorx, Inc. | Multilumen brachytherapy balloon catheter |
-
2002
- 2002-11-06 US US10/290,002 patent/US6923754B2/en not_active Expired - Lifetime
-
2003
- 2003-10-28 DK DK03774946.2T patent/DK1558324T3/en active
- 2003-10-28 WO PCT/US2003/033775 patent/WO2004043531A2/en active Application Filing
- 2003-10-28 AU AU2003283014A patent/AU2003283014A1/en not_active Abandoned
- 2003-10-28 CA CA2504965A patent/CA2504965C/en not_active Expired - Fee Related
- 2003-10-28 JP JP2004551571A patent/JP4563180B2/en not_active Expired - Fee Related
- 2003-10-28 AT AT03774946T patent/ATE511874T1/en active
- 2003-10-28 PT PT03774946T patent/PT1558324E/en unknown
- 2003-10-28 EP EP10182087A patent/EP2305340B1/en not_active Expired - Lifetime
- 2003-10-28 EP EP03774946A patent/EP1558324B1/en not_active Expired - Lifetime
- 2003-10-28 ES ES03774946T patent/ES2365331T3/en not_active Expired - Lifetime
-
2004
- 2004-05-19 US US10/849,410 patent/US6955641B2/en not_active Expired - Lifetime
-
2005
- 2005-04-14 US US11/105,856 patent/US7214178B2/en not_active Expired - Lifetime
- 2005-06-17 US US11/155,789 patent/US7935044B2/en active Active
-
2007
- 2007-10-31 US US11/981,063 patent/US7942802B2/en active Active
-
2011
- 2011-03-22 US US13/053,262 patent/US8398535B2/en not_active Expired - Lifetime
- 2011-04-08 US US13/082,711 patent/US8517906B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7942802B2 (en) | 2011-05-17 |
US6923754B2 (en) | 2005-08-02 |
WO2004043531A3 (en) | 2004-08-12 |
US20050182286A1 (en) | 2005-08-18 |
US8517906B2 (en) | 2013-08-27 |
EP2305340A1 (en) | 2011-04-06 |
US20050240074A1 (en) | 2005-10-27 |
US7935044B2 (en) | 2011-05-03 |
ATE511874T1 (en) | 2011-06-15 |
DK1558324T3 (en) | 2011-09-19 |
EP1558324B1 (en) | 2011-06-08 |
ES2365331T3 (en) | 2011-09-29 |
US20040087827A1 (en) | 2004-05-06 |
US20110172485A1 (en) | 2011-07-14 |
AU2003283014A8 (en) | 2004-06-03 |
PT1558324E (en) | 2011-08-26 |
JP4563180B2 (en) | 2010-10-13 |
WO2004043531A2 (en) | 2004-05-27 |
EP2305340B1 (en) | 2012-08-22 |
US7214178B2 (en) | 2007-05-08 |
US20080064915A1 (en) | 2008-03-13 |
CA2504965A1 (en) | 2004-05-27 |
JP2006505346A (en) | 2006-02-16 |
US6955641B2 (en) | 2005-10-18 |
US20040215048A1 (en) | 2004-10-28 |
EP1558324A2 (en) | 2005-08-03 |
US20110184222A1 (en) | 2011-07-28 |
US8398535B2 (en) | 2013-03-19 |
AU2003283014A1 (en) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2504965C (en) | Vacuum device and method for treating tissue adjacent a body cavity | |
JP4002985B2 (en) | Double wall balloon catheter for treating proliferative tissue | |
US7413539B2 (en) | Treatment of a body cavity | |
US7517310B2 (en) | Methods for tissue irradiation with shielding | |
US8075469B2 (en) | Methods for asymmetrical irradiation of a body cavity | |
US8273006B2 (en) | Tissue irradiation | |
US8303477B2 (en) | Fluid radiation shield for brachytherapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20151028 |